var title_f3_56_3968="Electrical activity in AF";
var content_f3_56_3968=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrical activity in atrial fibrillation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 280px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During atrial fibrillation there are multiple reentrant circuits within the right and left atrium, resulting in nonuniform activitation of the atrial myocardium. These circuits, which produce multiple wavelets, often occur around the normal structures of the atrial including the orifices of the superior (SVC) and inferior (IVC) vena cavae, the orifice of the pulmonary veins (PVs), and the right (RAA) and left (LAA) atrial appendages.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3968=[""].join("\n");
var outline_f3_56_3968=null;
var title_f3_56_3969="Right hemothorax";
var content_f3_56_3969=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1140px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/61778/Right_hemothorax_movie.mp4?title=Right+hemothorax\" style=\"width:496px;height:320px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ultrasound of right hemothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This ultrasound video clip reveals fluid in the pleural space and a small portion of the lung parenchyma just superior to the liver.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Greg Snead, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3969=[""].join("\n");
var outline_f3_56_3969=null;
var title_f3_56_3970="Positions for insertion of contraceptive devices";
var content_f3_56_3970=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F85977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F85977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Positions for insertion of contraceptive devices",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 637px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The woman should use&nbsp;the position that&nbsp;is most comfortable for her when inserting her diaphragm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3970=[""].join("\n");
var outline_f3_56_3970=null;
var title_f3_56_3971="Postpolypectomy electrocoagulation syndrome";
var content_f3_56_3971=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postpolypectomy electrocoagulation syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3971/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3971/contributors\">",
"     Jerome D Waye, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3971/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3971/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3971/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3971/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/56/3971/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpolypectomy electrocoagulation syndrome (also known as postpolypectomy syndrome and transmural burn syndrome) refers to the development of abdominal pain, fever, leukocytosis, and peritoneal inflammation in the absence of frank perforation that occurs after polypectomy with electrocoagulation. Recognition of postpolypectomy syndrome is important to avoid unnecessary exploratory laparotomy since it resolves with conservative treatment in the majority of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postpolypectomy syndrome was reported in six patients out of 16,318 colonoscopies performed between 1994 and 2002 in a large integrated health system [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Earlier reports estimated it to occur in 0.5 to 1.2 percent of patients undergoing polypectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another series described three types of cautery injury in 4784 consecutive polypectomies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/4\">",
"       4",
"      </a>",
"      ]. Two patients had frank perforation and five had \"mini-perforation\", while 24 (0.5 percent) developed the postpolypectomy electrocoagulation syndrome.",
"     </li>",
"     <li>",
"      Another report included 1190 patients who underwent 1576 polypectomies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/5\">",
"       5",
"      </a>",
"      ]. Postpolypectomy syndrome was the second most common complication (after bleeding) occurring in 0.5 percent of polypectomies. By contrast, no cases were described in a report involving 1672 polypectomies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study on 2106 polypectomies in 1252 patients reported that 3 patients (0.14 percent) were admitted to the hospital for symptoms consistent with this syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/7\">",
"       7",
"      </a>",
"      ]. All resolved with medical therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The increasing adoption of submucosal saline elevation of large polyps prior to transection may have reduced the incidence of postpolypectomy syndrome, but there are no large studies. A submucosal fluid injection prior to polypectomy (endoscopic mucosal resection) should theoretically decrease the occurrence of a transmural burn by increasing the thickness of the submucosal layer. However, four cases of post-polypectomy syndrome were reported in a series of 177 patients (2.2 percent of cases) where endoscopic mucosal resection was performed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28968?source=see_link\">",
"     \"Endoscopic removal of large colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpolypectomy syndrome develops when electrical current applied during polypectomy extends past the mucosa into the muscularis propria and serosa, resulting in a transmural burn without perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/9\">",
"     9",
"    </a>",
"    ]. Serosal irritation leads to a localized inflammatory response that manifests clinically as a localized peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postpolypectomy syndrome occurs most often after the removal of large (&gt;2 cm) sessile polyps, which usually require large amounts and long duration of thermal energy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/4\">",
"     4",
"    </a>",
"    ]. Inadvertent capture of a piece of normal adjacent mucosa within the snare loop during snare placement over a polyp can result in this condition when cautery transects both portions of tissue (mucosa and polyp) (",
"    <a class=\"graphic graphic_figure graphicRef53817 \" href=\"UTD.htm?35/27/36275\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients usually present within 12 hours, but symptoms may occur up to five days after the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/2\">",
"     2",
"    </a>",
"    ]. The majority complain of mild ache and tenderness in the region of the polypectomy site. Some patients have localized abdominal tenderness, rigidity, fever, leukocytosis, and tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/9\">",
"     9",
"    </a>",
"    ], a symptom complex that closely resembles colonic perforation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis should be suspected in patients who develop the clinical features described above following polypectomy with electrocautery, particularly those who had large sessile polyps removed. The distinction from frank perforation requires radiographic evaluation, which is best accomplished with an abdominal CT scan. In postpolypectomy electrocoagulation syndrome there is focal thickening of the colonic wall and periluminal fat stranding. By contrast, the presence of free intraperitoneal or retroperitoneal air suggests that perforation has occurred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is conservative, consisting of intravenous fluids, nothing by mouth, bedrest, and antibiotics until symptoms improve. In one report, hospitalization was required in approximately 20 percent of patients, all of whom responded to the above treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3971/abstract/2\">",
"     2",
"    </a>",
"    ]. Outpatient management with clear liquids and oral antibiotics is reasonable in patients with mild symptoms.",
"   </p>",
"   <p>",
"    We generally recommend the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (500 mg PO twice daily) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (500 mg PO three times daily) for up to five days. Patients whose symptoms have not responded or have worsened during this interval should be immediately reevaluated. In the presence of free intraperitoneal air, treatment is directed toward the perforation. No long-term sequelae have been described following postpolypectomy syndrome; thus patients should be reassured of an excellent prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postpolypectomy electrocoagulation syndrome refers to the development of abdominal pain, fever, leukocytosis, and peritoneal inflammation in the absence of frank perforation following polypectomy with electrocoagulation. Recognition of postpolypectomy syndrome is important to avoid unnecessary exploratory laparotomy, since it resolves with conservative treatment in the majority of patients.",
"     </li>",
"     <li>",
"      Postpolypectomy syndrome occurs most often after the removal of large (&gt;2 cm) sessile polyps, which usually require large amounts and long duration of thermal energy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients usually present within 12 hours, but symptoms may occur up to five days after the procedure. Most patients complain of mild ache and tenderness in the region of the polypectomy site and do not require hospitalization. Some patients have localized abdominal tenderness, rigidity, fever, leukocytosis, and tachycardia, a symptom complex that closely resembles colonic perforation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis should be suspected in patients who develop the clinical features described above following polypectomy with electrocautery, particularly those who had large sessile polyps removed. The distinction from frank perforation requires radiographic evaluation, which is best accomplished with an abdominal CT scan. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients whose symptoms warrant hospitalization, we suggest conservative treatment with intravenous fluids, nothing by mouth, bedrest, and antibiotics until symptoms improve (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Most patients with mild symptoms will not need any treatment beyond reassurance. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/1\">",
"      Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006; 145:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/2\">",
"      Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol 1992; 15:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/3\">",
"      Waye JD, Kahn O, Auerbach ME. Complications of colonoscopy and flexible sigmoidoscopy. Gastrointest Endosc Clin N Am 1996; 6:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/4\">",
"      Christie JP, Marrazzo J 3rd. \"Mini-perforation\" of the colon--not all postpolypectomy perforations require laparotomy. Dis Colon Rectum 1991; 34:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/5\">",
"      Nivatvongs S. Complications in colonoscopic polypectomy: lessons to learn from an experience with 1576 polyps. Am Surg 1988; 54:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/6\">",
"      Nelson DB, McQuaid KR, Bond JH, et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002; 55:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/7\">",
"      Choo WK, Subhani J. Complication rates of colonic polypectomy in relation to polyp characteristics and techniques: a district hospital experience. J Interv Gastroenterol 2012; 2:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/8\">",
"      Ferrara F, Luigiano C, Ghersi S, et al. Efficacy, safety and outcomes of 'inject and cut' endoscopic mucosal resection for large sessile and flat colorectal polyps. Digestion 2010; 82:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3971/abstract/9\">",
"      Waye JD. The postpolypectomy coagulation syndrome. Gastrointest Endosc 1981; 27:184.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2669 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-ED3CA7AB47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3971=[""].join("\n");
var outline_f3_56_3971=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2669\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2669|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/27/36275\" title=\"figure 1\">",
"      Removal large sessile polyp",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28968?source=related_link\">",
"      Endoscopic removal of large colonic polyps",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_56_3972="Alglucosidase alfa: Patient drug information";
var content_f3_56_3972=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alglucosidase alfa: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/44/44741?source=see_link\">",
"     see \"Alglucosidase alfa: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/40/42629?source=see_link\">",
"     see \"Alglucosidase alfa: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2932456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lumizyme&reg;;",
"     </li>",
"     <li>",
"      Myozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10304109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Myozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10892569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2917181",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may happen. Tell your doctor about any fever, rash, flushing, itching, flu-like signs, or trouble breathing that you might have during infusion and for 3 hours after it is done. You may be given drugs to avoid some of these signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3860402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have any heart or lung disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3986858",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get this drug only from the Lumizyme ACE Program&reg;.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10892576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Pompe disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10892570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2917180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alglucosidase alfa or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10892572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10892582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697879",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever, chills, itching, hives, chest pain or pressure, or shortness of breath when drug is given. Other drugs may be given to avoid these.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698348",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3532549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals and good mouth care may help. Older children may suck hard, sugar-free candy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10892574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10892578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694652",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Diphenhydramine and acetaminophen may be given before this drug to lower itching and fever.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10892571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10892575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16065 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.181.191-2D925142A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3972=[""].join("\n");
var outline_f3_56_3972=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932456\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10304109\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892569\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892576\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892570\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892572\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892582\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892574\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892578\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892571\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10892575\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/44/44741?source=related_link\">",
"      Alglucosidase alfa: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/40/42629?source=related_link\">",
"      Alglucosidase alfa: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_56_3973="Melasma forehead";
var content_f3_56_3973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Melasma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mottled hyperpigmented patches are present on the forehead.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3973=[""].join("\n");
var outline_f3_56_3973=null;
var title_f3_56_3974="Leucovorin: Pediatric drug information";
var content_f3_56_3974=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Leucovorin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"    see \"Leucovorin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?9/48/9988?source=see_link\">",
"    see \"Leucovorin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F11508393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lederle Leucovorin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Methotrexate",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Folic Acid Derivative",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"      see \"Leucovorin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Treatment of weak folic acid antagonist overdosage (eg, pyrimethamine, trimethoprim): Oral: 5-15 mg/day for 3 days or until blood counts are normal or 5 mg every 3 days; doses of 6 mg/day are needed for patients with platelet counts &lt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Folate deficient megaloblastic anemia: I.M.: &le;1 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Megaloblastic anemia secondary to congenital deficiency of dihydrofolate reductase: I.M.: 3-6 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Leucovorin rescue (following methotrexate dosing of 12-15 g/m",
"     <sup>",
"      2",
"     </sup>",
"     ): I.V.: 10 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     (15 mg in adults) to start, then 10 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     (15 mg in adults) every 6 hours orally for 72 hours; if serum creatinine 24 hours after methotrexate administration is elevated &ge;50%",
"     <b>",
"      or",
"     </b>",
"     the serum methotrexate concentration is &gt;5 x 10",
"     <sup>",
"      -6",
"     </sup>",
"     M, increase leucovorin dose to 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose (150 mg in adults) every 3 hours until serum methotrexate concentration is less than 1 x 10",
"     <sup>",
"      -8",
"     </sup>",
"     M (see graph for further dosing recommendations as a function of plasma methotrexate concentration vs time); if methotrexate clearance is delayed, continue leucovorin therapy until methotrexate concentration is 0.05 x 10",
"     <sup>",
"      -8",
"     </sup>",
"     M",
"    </p>",
"    (",
"    <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/60/12230\">",
"     See Leucovorin rescue dose",
"    </a>",
"    )",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Prevention of pyrimethamine hematologic toxicity: Infants, Children, Adolescents, and Adults: Oral: Dosage varies according to specific toxoplasmosis regimen (treatment or prophylaxis), see pyrimethamine monograph for specific regimen details (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colorectal cancer: Adults: I.V.: 200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     in combination with fluorouracil 370 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     or 20 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     used in combination with fluorouracil 425 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ; treatment is daily for 5 days and repeated at 4-5 week intervals; refer to individual protocols",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate overdose:",
"     <b>",
"      Note:",
"     </b>",
"     The amount of leucovorin administered should equal the amount of methotrexate inadvertently administered. I.V.: 1 mg per mg of methotrexate inadvertently administered; 100-1000 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 3-6 hours has been used; administer until methotrexate concentrations decrease to goal concentration or longer if methotrexate concentrations are unavailable or if patient has renal dysfunction or third-space storage (ascite, pleural effusion)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     An approximate nomogram for leucovorin rescue in cancer patients receiving high-dose methotrexate based upon a 48-hour methotrexate concentration may be considered (Widemann, 2006). Leucovorin dosage and frequency based on the methotrexate concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;80 micromole/L: 1000 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;8 to &lt;80 micromole/L: 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;2 to &lt;8 micromole/L: 10 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;0.1 to &lt;2 micromole/L: 10 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Use of I.T. leucovorin is not advised (Jardine, 1996; Smith, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Post I.T. methotrexate: I.V.: Post high-dose methotrexate: 100-1000 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose until the serum methotrexate concentration is less than 1 x 10",
"     <sup>",
"      -7",
"     </sup>",
"     molar",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cofactor therapy in methanol toxicity: I.V.: 1 mg/kg (maximum dose: 50 mg) over 30-60 minutes every 4-6 hours. Therapy should continue until methanol and formic acid have been completely eliminated (Barceloux, 2002)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [strength expressed as base]: 50 mg, 100 mg, 200 mg, 350 mg, 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [strength expressed as base, preservative free]: 10 mg/mL (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral [strength expressed as base]: 5 mg, 10 mg, 15 mg, 25 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:",
"     <b>",
"      This drug should be given parenterally instead of orally in patients with GI toxicity, nausea, vomiting, and when individual doses are &gt;25 mg.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.M., I.V.: Reconstitute 50 mg or 100 mg powder for injection vials with 5-10 mL SWI (350 mg vial requires 17 mL diluent resulting in 20 mg/mL final concentration); for I.V. administration, infuse at a maximum rate of 160 mg/minute;",
"     <b>",
"      not for intrathecal or intraventricular administration.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F187408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      10",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, sterile water for injection, bacteriostatic water, bacteriostatic NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, anidulafungin, aztreonam, bleomycin, cefepime, cisplatin, cladribine, cyclophosphamide, docetaxel, doxorubicin, doxorubicin liposome, etoposide phosphate, filgrastim, fluconazole, fluorouracil, furosemide, gemcitabine, granisetron, heparin, irinotecan, linezolid, methotrexate, metoclopramide, mitomycin, oxaliplatin, pemetrexed, piperacillin/tazobactam, tacrolimus, teniposide, thiotepa, vinblastine, vincristine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, droperidol, foscarnet, sodium bicarbonate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Bleomycin, cisplatin, cyclophosphamide, doxorubicin, fluorouracil, furosemide, heparin, methotrexate, metoclopramide, mitomycin, vinblastine, vincristine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ceftriaxone, Ddroperidol.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1059682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for injection: Store at room temperature of 25&deg;C (77&deg;F). Protect from light. Solutions reconstituted with bacteriostatic water for injection USP must be used within 7 days. When doses &gt;10 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     are used, prepare leucovorin with preservative free SWI to decrease the amount of benzyl alcohol intake; solutions reconstituted with SWI must be used immediately. Parenteral admixture is stable for 24 hours stored at room temperature (25&deg;C) and for 4 days when stored under refrigeration (4&deg;C).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for injection: Prior to dilution, store vials under refrigeration at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). Protect from light.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Store at room temperature of 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduction of toxic effects of high dose methotrexate (&ldquo;leucovorin rescue&rdquo;); to diminish the toxicity and counteract the effects of impaired methotrexate elimination or as an antidote for folic acid antagonist overdosage; treatment of folate deficient megaloblastic anemias of infancy, sprue, or pregnancy; nutritional deficiency when oral folate therapy is not possible; adjunctive treatment with sulfadiazine and pyrimethamine to prevent hematologic toxicity; combined with fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer (FDA approved in adults); has also been used as adjunctive cofactor therapy in methanol toxicity",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Leucovorin may be confused with Leukeran&reg;, Leukine&reg;, LEVOleucovorin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Folinic acid may be confused with folic acid",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Folinic acid is an error prone synonym and should not be used",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F187407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash, pruritus, erythema, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Thrombocytosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Wheezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylactoid reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to leucovorin or any component; pernicious anemia and other megaloblastic anemias secondary to the lack of vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     ; not to be administered by intrathecal or intraventricular route (may be harmful or fatal)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5940044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral therapy is recommended over oral therapy in cases where the patient is unable to tolerate oral treatment due to vomiting. Due to saturation of oral absorption with oral doses &gt;25 mg, I.V. administration is recommended for doses &gt;25 mg. Methotrexate serum concentrations should be monitored closely to determine the dose and duration of leucovorin rescue. Leucovorin doses may be increased, frequencies of administration altered, and duration of therapy increased depending upon the methotrexate clearance. Ascites, pleural effusion, renal insufficiency, and inadequate hydration may prolong methotrexate clearance. Refer to individual protocols or \"Leucovorin Rescue Dose\" graph for leucovorin dosage adjustment recommendations.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer promptly; when the time interval between administration of folic acid antagonists and leucovorin rescue increases, its effectiveness in treatment of toxicity diminishes. In the treatment of accidental overdosages of intrathecally administered folic acid antagonists, do not administer leucovorin intrathecally as it",
"     <b>",
"      may be harmful or fatal if administered intrathecally",
"     </b>",
"     . Leucovorin enhances the toxicity of fluorouracil; when used in combination, the dosage of fluorouracil should be reduced. Combination therapy should not be initiated or continued in patients who have symptoms of GI toxicity of any severity until the symptoms have resolved; rapid clinical deterioration including death may occur; monitor combination use closely. Concomitant use with trimethoprim/sulfamethoxazole for the acute treatment of",
"     <i>",
"      Pneumocystis jirovecii",
"     </i>",
"     pneumonia in patients with HIV infection has been associated with increased rates of treatment failure and morbidity.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F187338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capecitabine: Leucovorin Calcium-Levoleucovorin may enhance the adverse/toxic effect of Capecitabine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluorouracil (Systemic): Leucovorin Calcium-Levoleucovorin may enhance the adverse/toxic effect of Fluorouracil (Systemic). This effect is associated with the ability of leucovorin or levoleucovorin to enhance the anticancer effects of fluorouracil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluorouracil (Topical): Leucovorin Calcium-Levoleucovorin may enhance the adverse/toxic effect of Fluorouracil (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Leucovorin Calcium-Levoleucovorin may decrease the serum concentration of Fosphenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucarpidase: May decrease serum concentrations of the active metabolite(s) of Leucovorin Calcium-Levoleucovorin. Specifically, 6S-5-methyltetrahydrofolateconcentrations may be reduced. Glucarpidase may decrease the serum concentration of Leucovorin Calcium-Levoleucovorin. Management: Avoid leucovorin administration within 2 hours of glucarpidase dosing.  Continue to administer the pre-glucarpidase leucovorin dose for at least the first 48 hours after glucarpidase administration, and dose based on methotrexate concentration thereafter.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PHENobarbital: Leucovorin Calcium-Levoleucovorin may decrease the serum concentration of PHENobarbital.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Leucovorin Calcium-Levoleucovorin may decrease the serum concentration of Phenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: Leucovorin Calcium-Levoleucovorin may decrease the serum concentration of Primidone. Additionally, leucovorin/levoleucovorin may decrease concentrations of active metabolites of primidone (e.g., phenobarbital).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raltitrexed: Leucovorin Calcium-Levoleucovorin may diminish the therapeutic effect of Raltitrexed.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: Leucovorin Calcium-Levoleucovorin may diminish the therapeutic effect of Trimethoprim.  Management: Avoid concurrent use of leucovorin or levoleucovorin with trimethoprim (plus sulfamethoxazole) for",
"     <i>",
"      Pneumocystis jiroveci",
"     </i>",
"     pneumonia.  If trimethoprim is used for another indication, monitor closely for reduced efficacy.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5524281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Leucovorin is a biologically active form of folic acid. Adequate amounts of folic acid are recommended during pregnancy. Refer to Folic Acid monograph.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1059684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Leucovorin rescue: CBC with differential; plasma methotrexate concentrations, serum creatinine. Leucovorin is continued until the plasma methotrexate concentration is less than 1 x 10",
"     <sup>",
"      -7",
"     </sup>",
"     molar or &lt;0.5 x 10",
"     <sup>",
"      -7",
"     </sup>",
"     molar in situations of delayed methotrexate clearance. Each dose of leucovorin is increased if the plasma methotrexate concentration is excessively high. With 4- to 6-hour high-dose methotrexate infusions, plasma drug values in excess of 5 x 10",
"     <sup>",
"      -5",
"     </sup>",
"     and 10",
"     <sup>",
"      -6",
"     </sup>",
"     molar at 24 and 48 hours after starting the infusion, respectively, are often predictive of delayed methotrexate clearance; see leucovorin rescue dose graph.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     When used with fluorouracil: CBC with differential, platelets, LFTs, electrolytes",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A derivative of tetrahydrofolic acid, a reduced form of folic acid; does not require a reduction by dihydrofolate reductase for activation; allows for purine and thymidine synthesis, a necessity for normal erythropoiesis; leucovorin supplies the necessary cofactor blocked by methotrexate; actively competes with methotrexate for transport sites, displaces methotrexate from intracellular binding sites, and restores active folate stores required for DNA/RNA synthesis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Methanol toxicity treatment: Formic acid (methanol&rsquo;s toxic metabolite) is normally metabolized to carbon dioxide and water by 10-formyltetrahydrofolate dehydrogenase after being bound to tetrahydrofolate. Administering a source of tetrahydrofolate may aid the body in eliminating formic acid.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1059691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Within 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Within 5 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1059692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral, I.M.: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Rapidly converted to (5MTHF) 5-methyl-tetrahydrofolate (active) in the intestinal mucosa and by the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral absorption is saturable in doses &gt;25 mg; apparent bioavailability:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet, 25 mg: 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet, 50 mg: 75%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet, 100 mg: 37%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet, 200 mg: 31%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Injection solution, when administered orally, provides equivalent bioavailability",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Adults: ~4-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: ~2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V. total folates: 10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     5MTHF: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Primarily in urine (80% to 90%) with small losses appearing in feces (5% to 8%)",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F12807804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 5 mg/mL oral suspension may be prepared with tablets, Cologel&reg;, and a 2:1 mixture of simple syrup and wild cherry syrup. Crush twenty-four 25 mg tablets in a glass mortar and reduce to a fine powder; transfer powder to amber bottle. Add 30 mL Cologel&reg; and shake mixture thoroughly. Add a quantity of syrup mixture sufficient to make 120 mL. Label &ldquo;shake well&rdquo; and &ldquo;refrigerate&rdquo;. Stable for 28 days refrigerated.",
"    </p>",
"    <div class=\"reference\">",
"     Lam MS, \"Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs,\"",
"     <i>",
"      Pharmacotherapy",
"     </i>",
"     , 2011, 31(2):164-92.",
"     <span class=\"pubmed-id\">",
"      21275495",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, \"Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-164. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/56/3974/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barceloux DG, Bond GR, Krenzelok EP, et al, \"American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning,\"",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 2002, 40(4):415-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/56/3974/abstract-text/12216995/pubmed\" id=\"12216995\" target=\"_blank\">",
"        12216995",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jardine LF, Ingram LC, and Bleyer WA, \"Intrathecal Leucovorin After Intrathecal Methotrexate Overdose,\"",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 1996, 18(3):302-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/56/3974/abstract-text/8689347/pubmed\" id=\"8689347\" target=\"_blank\">",
"        8689347",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith SW and Nelson LS, \"Case Files of the New York City Poison Control Center: Antidotal Strategies for the Management of Methotrexate Toxicity,\"",
"      <i>",
"       J Med Toxicol",
"      </i>",
"      , 2008, 4(2):132-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/56/3974/abstract-text/18570175/pubmed\" id=\"18570175\" target=\"_blank\">",
"        18570175",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Widemann BC and Adamson PC, \"Understanding and Managing Methotrexate Nephrotoxicity,\"",
"      <i>",
"       Oncologist",
"      </i>",
"      , 2006, 11(6):694-703.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/56/3974/abstract-text/16794248/pubmed\" id=\"16794248\" target=\"_blank\">",
"        16794248",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12544 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3974=[""].join("\n");
var outline_f3_56_3974=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11508393\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059685\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059679\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187344\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187331\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059689\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187408\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059682\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059688\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187410\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187407\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059693\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5940044\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059678\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299583\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187338\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187340\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5524281\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059684\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059677\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059691\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059692\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12807804\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12544\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12544|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/60/12230\" title=\"Leucovorin rescue dose\">",
"      Leucovorin rescue dose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12544|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=related_link\">",
"      Leucovorin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/48/9988?source=related_link\">",
"      Leucovorin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_56_3975="Cutaneous innervation of the lower extremity";
var content_f3_56_3975=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F60926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F60926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Cutaneous innervation of the lower extremity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 701px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3975=[""].join("\n");
var outline_f3_56_3975=null;
var title_f3_56_3976="Disseminated gonococcal infection";
var content_f3_56_3976=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Disseminated gonococcal infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Don L Goldenberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3976/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/56/3976/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated gonococcal infection (DGI) results from bacteremic spread of the sexually transmitted pathogen, Neisseria gonorrhoeae, which can lead to a variety of clinical symptoms and signs, such as tenosynovitis, dermatitis, and multiple skin lesions.",
"   </p>",
"   <p>",
"    This topic will discuss the epidemiology, clinical manifestations, diagnosis and treatment of DGI. The clinical manifestations, diagnosis and treatment of uncomplicated gonococcal infection (eg, cervicitis and urethritis) are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16637766\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated gonococcal infection (DGI) occurs in 0.5 to 3 percent of patients infected with Neisseria gonorrhoeae. Most are younger than 40 years of age, although DGI can occur in virtually any age group.",
"   </p>",
"   <p>",
"    DGI is a common cause of acute polyarthralgias, polyarthritis, or oligoarthritis in young, healthy patients. Males or females may be affected. As an example, one study of 151 consecutive patients with acute nontraumatic arthritis or arthralgia seen at the University of Washington hospitals found that N. gonorrhoeae was the most common cause of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/1\">",
"     1",
"    </a>",
"    ]. DGI has a number of unique and characteristic clinical features that allow it to be distinguished from other types of infectious arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY AND PREDISPOSING FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The probability that a localized gonococcal infection will spread to joints and other tissues depends upon specific host, microbial, and possibly immune factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Host factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated gonococcal infection (DGI) is approximately three times more common in women than men. A history of recent symptomatic genital infection is uncommon in men or women with DGI; asymptomatic mucosal infection is thought to be the predisposing factor for dissemination in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/2\">",
"     2",
"    </a>",
"    ]. Other important risk factors for DGI include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recent menstruation",
"     </li>",
"     <li>",
"      Pregnancy or the immediate post partum state",
"     </li>",
"     <li>",
"      Congenital or acquired complement deficiencies (C5, C6, C7, or C8) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Systemic lupus erythematosus [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Microbial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;N. gonorrhoeae contain a variety of virulence and growth factors associated with an increased propensity to cause DGI. Strains that are associated with dissemination have the following characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They contain low molecular weight protein 1A (porin Serotype IA)",
"     </li>",
"     <li>",
"      They require arginine, hypoxanthine, and uracil for growth (Auxotype AHU)",
"     </li>",
"     <li>",
"      They are usually highly sensitive to penicillin, although strains that are penicillinase-producing via a plasmid mechanism may also cause DGI [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability of Neisseria gonorrhoeae to cause disseminated gonococcal infection requires that such strains resist the bactericidal action of normal human serum [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/8\">",
"       8",
"      </a>",
"      ]. The mechanisms by which certain strains of gonococci resist these bactericidal factors are not fully understood, but alterations in lipooligosaccharide structure may play a role [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Immune factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most patients with DGI respond dramatically and quickly to antimicrobial therapy (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Evaluation and management'",
"    </a>",
"    below), immune mechanisms may also be involved in the pathogenesis of DGI. This hypothesis is supported by the frequent absence of positive blood, skin, and synovial fluid cultures. As an example, N. gonorrhoeae are recovered from fewer than 50 percent of purulent synovial effusions due to DGI, positive blood cultures are found in less than one-third of patients, and skin lesions are almost always sterile. While these sterile cultures may be a result of the fastidious growth requirements of N. gonorrhoeae, the organisms are easily recovered from the genitourinary tract or other local sites in most cases of DGI. Thus, the sterile synovitis, tenosynovitis, and dermatitis associated with DGI may not always require viable N. gonorrhoeae, and other etiologies of these conditions may be important.",
"   </p>",
"   <p>",
"    Studies using polymerase chain reaction (PCR) have detected gonococcal DNA in the synovial cavity of patients with DGI [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Nucleic acid amplification testing has also been used to detect N. gonorrhoeae in skin lesions and throat samples that were culture negative [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/12\">",
"     12",
"    </a>",
"    ]. However, some subjects were culture-negative and PCR negative, suggesting that in certain cases there were no detectable bacteria in the joint at the time of persistent synovitis.",
"   </p>",
"   <p>",
"    Further evidence for an immune component in DGI is derived from the observation that gonococcal cell-wall components, gonococcal antibody, and complement have been demonstrated in skin lesions. Circulating immune complexes have also been detected in some but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with disseminated gonococcal infection (DGI) typically present with one of two syndromes (",
"    <a class=\"graphic graphic_table graphicRef56577 \" href=\"UTD.htm?16/46/17131\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A triad of tenosynovitis, dermatitis, and polyarthralgias without purulent arthritis (",
"      <a class=\"graphic graphic_picture graphicRef59399 \" href=\"UTD.htm?40/27/41407\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef69978 \" href=\"UTD.htm?26/23/26996\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Purulent arthritis without associated skin lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Separation between these two classic forms of DGI is not always absolute. Some patients with the triad, for example, may progress to purulent arthritis if the disease is not recognized and treated. In addition, a small number of patients with purulent arthritis may also have tenosynovitis or skin lesions. The pathogenic mechanism responsible for these strikingly different clinical presentations is poorly understood, although it may in part depend upon differences in the infecting strain of the organism.",
"   </p>",
"   <p>",
"    Patients with either of the above clinical syndromes usually do not simultaneously manifest signs and symptoms of a gonococcal infection involving mucous membranes, even though localized infection involving the urethra, cervix, rectum or pharynx typically precedes the onset of DGI. Other manifestations such as endocarditis, meningitis and osteomyelitis can also occur. However, these complications are so rare that they will not be discussed in this topic review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     The tenosynovitis, dermatitis, polyarthralgia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with this form of DGI typically present with the following clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The acute stage of illness is characterized by fever, chills, and generalized malaise. Fever may spontaneously disappear or diminish in magnitude as the disorder progresses.",
"     </li>",
"     <li>",
"      Tenosynovitis is a unique finding in this form of DGI, and is unusual in other forms of infectious arthritis. Often multiple tendons are simultaneously inflamed, particularly at the wrist, fingers, ankle, and toes.",
"     </li>",
"     <li>",
"      Dermatitis typically consists of painless lesions that often are few in number. Lesions are usually pustular or vesiculopustular, although hemorrhagic macules, papules, bullae, or nodules rarely occur (",
"      <a class=\"graphic graphic_picture graphicRef71303 \" href=\"UTD.htm?18/49/19219\">",
"       picture 3",
"      </a>",
"      ). Pustular or vesicular skin lesions are often transient and even without treatment may only last for three to four days. Patients may be unaware of the presence of skin lesions. Rarely, patients with DGI can develop lesions that are urticarial or others that resemble erythema nodosum or erythema multiforme [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29286?source=see_link&amp;anchor=H3288317#H3288317\">",
"       \"Cutaneous manifestations of gonorrhea\", section on 'Disseminated gonococcal infection'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Skin lesions rarely number more than 40; and it is common to find between 2 and 10 lesions in an individual patient. Lesions are rarely present on the face [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"       13",
"      </a>",
"      ]. Although skin lesions and tenosynovitis can spontaneously regress even without treatment, joint involvement will usually progress unless specific treatment is given. The white blood cell count can be elevated or normal in patients with this form of DGI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Purulent arthritis without skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knees, wrists, and ankles are most commonly involved in patients with this form of DGI, and more than one joint may be simultaneously infected. Polyarthritis, when present, is typically asymmetric. Most patients are afebrile. In addition, clinical signs of infection at other body sites or disseminated infection involving the cardiac valves and meninges are rare.",
"   </p>",
"   <p>",
"    As noted above, however, there are patients who appear to overlap between the two forms of DGI. In some patients, for example, the illness seems to progress from an early stage in which the triad of tenosynovitis, dermatitis and polyarthralgia or polyarthritis is present to a later form in which only septic mono- or oligoarthritis is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in other forms of infectious arthritis, an accurate diagnosis requires a thorough history, physical examination, and laboratory studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the clinical manifestations cited above, a history of recent sexual activity can usually be elicited in most patients with disseminated gonococcal infection (DGI), although this may be overlooked by physicians or denied by patients. A recent history of symptomatic venereal disease is obtained in only a minority of patients; however, many give a history of past episodes of venereal infection. Women must be questioned about the timing of their latest menses, and the possibility of coexistent pregnancy should be investigated in those who have not recently menstruated. Most patients with DGI report feeling well up to the onset of the illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful physical examination is often needed to detect the characteristic skin lesions of DGI. Typical lesions may be mistakenly dismissed as unimportant furuncles or pimples by the patient or physician. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29286?source=see_link&amp;anchor=H3288317#H3288317\">",
"     \"Cutaneous manifestations of gonorrhea\", section on 'Disseminated gonococcal infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Careful evaluation of the joints is also important. It is not unusual to see patients with only one or two joints that are involved. Small or large joints may be affected, and symmetric joint involvement is uncommon. Tenosynovitis is often visible to the examining physician; its presence can usually be confirmed by eliciting pain along the tendon sheath with active or passive joint movement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous laboratory studies may be of utility in the diagnosis of DGI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Synovial fluid analysis is the best way to establish the diagnosis in patients who present with purulent arthritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20360?source=see_link\">",
"       \"Synovial fluid analysis and the diagnosis of septic arthritis\"",
"      </a>",
"      .) In contrast, those with the tenosynovitis, dermatitis, and polyarthralgia form of DGI typically have negative synovial fluid cultures.",
"      <br/>",
"      <br/>",
"      The mean synovial fluid leukocyte count in gonococcal arthritis is typically around 50,000",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       ;",
"      </span>",
"      in some cases, however, cell counts below 10,000",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      may be observed (",
"      <a class=\"graphic graphic_table graphicRef76506 \" href=\"UTD.htm?31/4/31820\">",
"       table 2",
"      </a>",
"      ). Chemistry studies of the joint fluid, such as the concentrations of glucose, lactate dehydrogenase, or protein have only limited value; a reduction in glucose concentration and elevation of LDH are consistent with a bacterial infection, but are not diagnostic or particularly sensitive [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At least two sets of blood cultures should be obtained from all patients with suspected DGI. Cultures are diagnostic when positive, and are also helpful in separating DGI from other conditions such as arthritis due to Neisseria meningitidis or Staphylococcus aureus, both of which may mimic the clinical features of DGI to a remarkable degree. Patients with the tenosynovitis, dermatitis, polyarthralgia form of DGI are more likely to have positive blood cultures than those presenting with purulent arthritis.",
"     </li>",
"     <li>",
"      Patients with the clinical features of DGI should have synovial, skin, urethral or cervical cultures, and rectal cultures submitted on Thayer-Martin media. Approximately 50 percent of patients with DGI have positive cultures from one of the last three mucosal sites [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"       13",
"      </a>",
"      ]. If associated urethritis is simultaneously present, a Gram stain of the urethral exudate should be obtained and examined for the presence of the gram negative diplococci characteristic of N. gonorrhoeae infection. Culture and Gram stain of specimens obtained from skin lesions or tendon sheaths are often (although not invariably) negative.",
"     </li>",
"     <li>",
"      All patients with known or suspected DGI should have a screening test for HIV infection and a syphilis serology since coexistent infection with other sexually transmitted diseases is common.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluation of the patient with recurrent DGI is discussed below. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Recurrent episodes of DGI'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An array of other infectious and noninfectious diseases may simulate disseminated gonococcal infection (DGI) (",
"    <a class=\"graphic graphic_table graphicRef72238 \" href=\"UTD.htm?23/7/23676\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bacterial arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical characteristics of meningococcal arthritis and DGI may be nearly identical [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/15\">",
"     15",
"    </a>",
"    ]. The following may be useful distinguishing features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study in which the clinical features of seven patients with meningococcal arthritis were compared with 39 patients with DGI found that DGI was less likely to have positive blood cultures (61 versus 83 percent) but much more likely to have positive cultures of the urethra or cervix (58 versus 0 percent).",
"     </li>",
"     <li>",
"      Meningococcal infection is usually a more severe disease than DGI; many patients with meningococcal arthritis also have clinical signs of sepsis or concurrent meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other forms of bacterial arthritis can also mimic the clinical features of DGI in some patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=see_link\">",
"     \"Septic arthritis in adults\"",
"    </a>",
"    .) As an example, acute purulent arthritis may occur in sexually active patients who use intravenous drugs. These patients may present with a monoarthritis or oligoarthritis, fever, and chills.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hepatitis B infection may develop fever, chills, polyarthritis, tenosynovitis, and rash. However, the rash associated with acute Hepatitis B infection is typically urticarial, and synovial fluid analysis usually shows noninflammatory fluid. Furthermore, the arthritis associated with hepatitis B is more often polyarticular and symmetric. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link\">",
"     \"Specific viruses that cause arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to these clinical features, patients with hepatitis B infection can usually be distinguished from those with DGI by the presence of elevated hepatocellular enzymes, and the serologic identification of hepatitis B surface antigen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Connective tissue diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactive arthritis, rheumatoid arthritis, and psoriatic arthritis may be confused with DGI (",
"    <a class=\"graphic graphic_table graphicRef72238 \" href=\"UTD.htm?23/7/23676\">",
"     table 3",
"    </a>",
"    ). Patients with the constellation of reactive arthritis, tenosynovitis, and urethritis (formerly Reiter syndrome), unlike those with typical DGI, also have one or more of the following: conjunctivitis; circinate balanitis; or keratoderma blenorrhagicum. Clinical and radiological evidence of sacroiliitis is also very suggestive of reactive arthritis or spondyloarthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, a therapeutic trial of antibiotics can help to differentiate between these disorders. Patients with reactive arthritis characteristically do not respond to treatment for N. gonorrhoeae, whereas response to treatment in DGI is usually rapid and unequivocal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute rheumatic fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rheumatic fever (poststreptococcal arthritis) may present with polyarthritis and rash in young adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    .) However, the rash of acute rheumatic fever is quite rare, and if present, it is usually transient and virtually never pustular or vesiculopustular. The diagnosis of acute rheumatic fever is based upon a constellation of findings that include microbiologic or serologic evidence of a recent streptococcal infection, and the presence of carditis or neurologic symptoms. Most patients with poststreptococcal arthritis have a characteristically rapid response to salicylates or other antiinflammatory drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with infective endocarditis may present with myalgias, arthralgias, fever, chills, and back pain symptoms that are possible to confuse with DGI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    .) However, most patients with infective endocarditis have prominent cardiac abnormalities and the majority have positive blood cultures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other infectious diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of viral and spirochetal infectious diseases may present with clinical features that overlap with features of DGI and may lead to diagnostic confusion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute HIV infection can coexist with and mimic the clinical features of DGI. Patients with acute HIV infection may develop rash, fever, chills, and arthralgias. However, joint effusions are uncommon in HIV infection, the rash is usually generalized, and mucus membrane involvement is often a dominant finding.",
"     </li>",
"     <li>",
"      Secondary syphilis may occasionally be confused with DGI. However, the rash of secondary syphilis usually consists of generalized, pustular lesions. Involvement of the palms and soles and generalized lymphadenopathy are also clues to the presence of syphilis.",
"     </li>",
"     <li>",
"      Viral infections such as parvovirus B19, measles, rubella, and several arboviral infections not commonly seen in the United States can also cause rash and arthritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link\">",
"       \"Specific viruses that cause arthritis\"",
"      </a>",
"      .) These patients can usually be distinguished from patients with DGI by the epidemiologic setting, the character and evolution of the rash, and associated findings such as lymphadenopathy or an exanthem.",
"     </li>",
"     <li>",
"      The characteristic erythema chronicum migrans rash and evolution of clinical symptoms should easily differentiate Lyme disease from DGI (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=see_link\">",
"       \"Epidemiology of Lyme disease\"",
"      </a>",
"      ). Lyme disease generally causes a monoarthritis, and epidemiologic as well as serologic criteria are helpful in confirming the diagnosis.",
"     </li>",
"     <li>",
"      Gout and other crystal-induced forms of arthritis may cause an acute monoarthritis with fever and chills. This form of monoarthritis is usually distinguished from DGI by synovial fluid analysis and the epidemiologic setting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     EVALUATION AND MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H223292\">",
"    <span class=\"h2\">",
"     Preferred antimicrobial regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    1 gram (either intravenously or intramuscularly) every 24 hours is the preferred initial treatment for disseminated gonococcal infection (DGI) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/16\">",
"     16",
"    </a>",
"    ]. Alternative regimens include intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    or ceftizoxime, each given as 1 gram every eight hours. Patients should also receive a single 1 gram oral dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    , for dual therapy of gonococcal infections and to cover potential C. trachomatis coinfection.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     Doxycycline",
"    </a>",
"    (100 mg twice a day for seven days) is an alternate second agent to use with ceftriaxone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H1115841#H1115841\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Approach to treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link\">",
"     \"Treatment of Chlamydia trachomatis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Agents other than parenteral cephalosporins are less useful given the widespread resistance of N. gonorrhoeae to various drug classes. Decreasing susceptibility of N. gonorrhoeae to the oral cephalosporin",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/44/16070?source=see_link\">",
"     cefixime",
"    </a>",
"    has also been reported in the United States, Asia, Europe, and other parts of the world [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Thus, this agent should not be used for initial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/20\">",
"     20",
"    </a>",
"    ]. The issue of drug resistance is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H7889004#H7889004\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Antibiotic resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of the lack of alternate effective agents, patients with a documented IgE-mediated hypersensitivity reaction to beta-lactams should undergo desensitization to allow administration of parenteral cephalosporins.",
"   </p>",
"   <p>",
"    Once initial clinical improvement is noted for 24 to 48 hours, the treatment course can be completed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    250 mg intramuscularly every 24 hours. Because of the emergence of resistance and decreasing susceptibility of N. gonorrhoeae to oral agents that have been used as &ldquo;step-down&rdquo; therapy, we suggest not using these agents unless culture and susceptibility testing of the isolate are available and document full susceptibility to the antibiotic of choice. (See",
"    <a class=\"local\" href=\"#H22\">",
"     '\"Step-down\" therapy from parenteral to oral treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Duration of treatment and the need for joint drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controlled clinical trials evaluating the duration of therapy have not been undertaken in patients with DGI. We agree with the United States Centers for Disease Control and Prevention guidelines to continue antibiotic therapy for at least seven days as long as the clinical signs of infection are gone or nearly gone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/16\">",
"     16",
"    </a>",
"    ]. Patients with the triad of tenosynovitis, dermatitis, and arthralgia or synovitis, who have small or absent joint effusions, typically respond dramatically and quickly to treatment.",
"   </p>",
"   <p>",
"    In contrast, clinical improvement and cure in patients with purulent arthritis may require parenteral therapy for 7 to 14 days. Patients with purulent arthritis should also undergo joint drainage. This can be accomplished either with repeated needle aspirations or arthroscopically. Open surgical or arthroscopic drainage should be utilized for patients in whom needle aspirate is not successful or adequate (as assessed by continuing effusions, leukocytosis, fever, or severe joint pain).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     \"Step-down\" therapy from parenteral to oral treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;As above, because of the emergence of resistance and decreasing susceptibility of N. gonorrhoea to oral agents that have traditionally been used as &ldquo;step-down&rdquo; therapy, we suggest not using these agents unless culture and susceptibility testing of the isolate are available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H7889004#H7889004\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Antibiotic resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If susceptibility testing demonstrates full sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/44/16070?source=see_link\">",
"     cefixime",
"    </a>",
"    , patients who lack septic arthritis and who respond promptly to parenteral therapy can complete their seven-day course of therapy with oral cefixime (400 mg twice daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. Alternately, in cases in which an isolate of N. gonorrhoeae has been identified and susceptibility to fluoroquinolones, penicillin,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    has been demonstrated, oral therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (500 mg twice daily),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    (500 four times daily), or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (100 mg twice daily) can also be used.",
"   </p>",
"   <p>",
"    However, many labs do not have the capability to perform N. gonorrhoeae culture and susceptibility testing. In the absence of such testing, these oral antibiotics should",
"    <strong>",
"     not",
"    </strong>",
"    be used for the therapy of disseminated N. gonorrhoeae and the course should be completed with a parenteral cephalosporin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Concurrent treatment for Chlamydial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current recommendation for the treatment of gonococcal infections is a combination regimen of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    . This regimen will also treat chlamydia, which is a frequent copathogen. The treatment of chlamydia is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H278540#H278540\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Preferred regimen for urogenital infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link\">",
"     \"Treatment of Chlamydia trachomatis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Treatment and assessment of sexual partners",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whenever possible, the sexual partners of patients with DGI should be located and offered treatment after they have undergone evaluation for symptomatic or asymptomatic infection with N. gonorrhoeae. Infected partners should receive therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    250 mg IM and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    (1 gram orally as a single dose).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     Doxycycline",
"    </a>",
"    (100 mg twice a day for seven days) is an alternate second agent to use with ceftriaxone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H1115841#H1115841\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Approach to treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Recurrent episodes of DGI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have more than one episode of DGI should be screened for the presence of a deficiency in one of the terminal components of complement by obtaining an assay for total hemolytic complement activity [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16637758\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disseminated gonococcal infection (DGI) results from bacteremic spread of the sexually transmitted pathogen, Neisseria gonorrhoeae. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DGI is a common cause of acute polyarthralgias, polyarthritis, or oligoarthritis in young, healthy patients. (See",
"      <a class=\"local\" href=\"#H16637766\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with disseminated gonococcal infection usually present with one of two syndromes: purulent arthritis alone or a triad of tenosynovitis, dermatitis, and polyarthralgias without frank arthritis. Patients with tenosynovitis often have systemic symptoms such as fever, chills and malaise. Those with purulent arthritis alone usually have involvement of the knees, wrists, or ankles without any systemic symptoms. When present, polyarthritis is typically asymmetric. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A recent history of gonorrhea is obtained in only a minority of patients; however, many give a history of past episodes of sexually transmitted infections. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A careful physical examination is needed to detect the characteristic skin lesions of DGI, which may be dismissed as incidental furuncles by the patient or physician. Tenosynovitis is confirmed by eliciting pain along the tendon sheath with active or passive joint movement. Patients with purulent arthritis may have either small or large joint involvement. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with clinical features of DGI should have synovial, skin, rectal, and urethral or cervical cultures submitted on Thayer-Martin media. Approximately 50 percent of patients with DGI have positive cultures from mucosal sites. Blood cultures are often positive among patients with the tenosynovitis syndrome while those with purulent arthritis are more likely to have a positive synovial fluid culture compared to a positive blood culture. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with DGI should be treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (1 gram either intramuscularly or intravenously every 24 hours) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      (1 gram orally in a single dose).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       Doxycycline",
"      </a>",
"      (100 mg twice a day for seven days) is an alternate second agent to use with ceftriaxone. Parenteral therapy with ceftriaxone should be given for seven days, although the dose can be changed following clinical improvement to 250 mg intramuscularly daily. Patients with the tenosynovitis triad usually improve quickly (eg, 72 hours), while patients with septic arthritis usually require ceftriaxone for 7 to 14 days along with joint drainage. (See",
"      <a class=\"local\" href=\"#H223292\">",
"       'Preferred antimicrobial regimen'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Duration of treatment and the need for joint drainage'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link&amp;anchor=H1115841#H1115841\">",
"       \"Treatment of uncomplicated gonococcal infections\", section on 'Approach to treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The above preferred treatment regimen for gonococcal infections is also effective against C. trachomatis, a frequent co-pathogen with N. gonorrhoeae. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Concurrent treatment for Chlamydial infection'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link&amp;anchor=H5623067#H5623067\">",
"       \"Treatment of Chlamydia trachomatis infection\", section on 'First-line agents'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Whenever possible, the sexual partners of patients with DGI should be located and offered treatment for both gonococcal and chlamydial infections. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Treatment and assessment of sexual partners'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/1\">",
"      Rompalo AM, Hook EW 3rd, Roberts PL, et al. The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis. Arch Intern Med 1987; 147:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/2\">",
"      O'Brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983; 62:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/3\">",
"      Phupong V, Sittisomwong T, Wisawasukmongchol W. Disseminated gonococcal infection during pregnancy. Arch Gynecol Obstet 2005; 273:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/4\">",
"      Petersen BH, Lee TJ, Snyderman R, Brooks GF. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 1979; 90:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/5\">",
"      Wise CM, Morris CR, Wasilauskas BL, Salzer WL. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med 1994; 154:2690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/6\">",
"      Britigan BE, Cohen MS, Sparling PF. Gonococcal infection: a model of molecular pathogenesis. N Engl J Med 1985; 312:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/7\">",
"      Rinaldi RZ, Harrison WO, Fan PT. Penicillin-resistant gonococcal arthritis. A report of four cases. Ann Intern Med 1982; 97:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/8\">",
"      Schoolnik GK, Buchanan TM, Holmes KK. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest 1976; 58:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/9\">",
"      Lewis LA, Choudhury B, Balthazar JT, et al. Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun 2009; 77:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/10\">",
"      Liebling MR, Arkfeld DG, Michelini GA, et al. Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum 1994; 37:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/11\">",
"      Muralidhar B, Rumore PM, Steinman CR. Use of the polymerase chain reaction to study arthritis due to Neisseria gonorrhoeae. Arthritis Rheum 1994; 37:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/12\">",
"      Read P, Abbott R, Pantelidis P, et al. Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swab. Sex Transm Infect 2008; 84:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/13\">",
"      Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005; 19:853.",
"     </a>",
"    </li>",
"    <li>",
"     Goldenberg DL. Gonococcal arthritis and other Neisserial infections. In: Arthritis and Allied Conditions, 12th Edition, McCarthy DJ, Koopman WS (Eds), Lea and Febiger, Philadelphia 1993. p.2025.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/15\">",
"      Andersson S, Krook A. Primary meningococcal arthritis. Scand J Infect Dis 1987; 19:51.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/17\">",
"      Centers for Disease Control and Prevention (CDC). Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011; 60:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/18\">",
"      Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 2001; 45:3603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/19\">",
"      Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 2009; 10:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3976/abstract/20\">",
"      Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61:590.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7603 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-0C50FA751B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3976=[""].join("\n");
var outline_f3_56_3976=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16637758\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16637766\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY AND PREDISPOSING FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Host factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Microbial factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Immune factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      The tenosynovitis, dermatitis, polyarthralgia syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Purulent arthritis without skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bacterial arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Connective tissue diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other infectious diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H223292\">",
"      Preferred antimicrobial regimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Duration of treatment and the need for joint drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      \"Step-down\" therapy from parenteral to oral treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Concurrent treatment for Chlamydial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Treatment and assessment of sexual partners",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Recurrent episodes of DGI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16637758\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7603\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7603|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/27/41407\" title=\"picture 1\">",
"      Disseminated gonorrhea skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/23/26996\" title=\"picture 2\">",
"      Disseminated gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/49/19219\" title=\"picture 3\">",
"      Gonococcal skin lesion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7603|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/46/17131\" title=\"table 1\">",
"      Symptoms of DGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/4/31820\" title=\"table 2\">",
"      Categories of synovial fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/7/23676\" title=\"table 3\">",
"      Differential dx of arthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29286?source=related_link\">",
"      Cutaneous manifestations of gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=related_link\">",
"      Epidemiology of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=related_link\">",
"      Septic arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=related_link\">",
"      Specific viruses that cause arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20360?source=related_link\">",
"      Synovial fluid analysis and the diagnosis of septic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=related_link\">",
"      Treatment of Chlamydia trachomatis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_56_3977="Atypical carcinoid lung";
var content_f3_56_3977=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atypical carcinoid tumor of the lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph showing an atypical carcinoid tumor of the lung. The tumor shows a growth pattern reminiscent of that seen in carcinoid tumors of the more usual type, but differs in that there is associated tumor necrosis as seen in the upper portion of the photomicrograph (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3977=[""].join("\n");
var outline_f3_56_3977=null;
var title_f3_56_3978="Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes";
var content_f3_56_3978=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/56/3978/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/56/3978/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanostomy tube insertion is among the most common operative procedures in childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/1\">",
"     1",
"    </a>",
"    ]. As such, tympanostomy tube surgery has considerable impact on the health of young children and upon medical economics.",
"   </p>",
"   <p>",
"    An overview of tympanostomy tubes, the post-operative care of the child with tympanostomy tubes, and the diagnosis and management of complications of tympanostomy tubes in children will be reviewed here. Chronic otitis media (otitis media with effusion), prevention of recurrent acute otitis media, and the prevention and management of tympanostomy tube otorrhea are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link\">",
"     \"Otitis media with effusion (serous otitis media) in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link\">",
"     \"Acute otitis media in children: Prevention of recurrence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 1 million tympanostomy tube insertions are performed annually in North America, primarily in children with chronic or recurrent otitis media refractory to nonsurgical management. About 7 percent of children in the United States have tympanostomy tubes inserted by age three years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/2\">",
"     2",
"    </a>",
"    ], with rates up to 30 percent reported in a managed care cohort attending day care [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of tympanostomy tube insertion in young children in the United States has declined since the introduction of the pneumococcal conjugate vaccine into the routine childhood immunization schedule in 2000. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute otitis media in children: Prevention of recurrence\", section on 'Pneumococcal conjugate vaccine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The middle ear is a closed space that requires periodic replenishment of mucosally absorbed air via the eustachian tube. The ventilating function of the eustachian tube is less well developed in young children than in adults. Underventilation of the middle ear results in negative pressure, which may lead to aspiration of nasopharyngeal secretions and transudation of intracellular fluid, important steps in the development of acute otitis media (AOM) and otitis media with effusion (OME, also called serous otitis media) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This information, combined with the observation that middle ear disease stabilized in some patients with perforations of the tympanic membrane (TM), led to attempts to provide middle ear ventilation via surgical perforation of the TM (myringotomy). Unfortunately, simple perforations of the TM close rapidly [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/5\">",
"     5",
"    </a>",
"    ]. In the early 1900s, various materials (eg, catgut, fish bones, lead wires, and gold rings) were used in efforts to keep the perforations open [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Successful ventilation of the middle ear by myringotomy and insertion of a straight, narrow polyethylene tube that remained in place for a few weeks was described in a series of patients in 1954 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/7\">",
"     7",
"    </a>",
"    ]. The initial tube design has been modified since then to achieve greater duration of function and lower rates of permanent perforation after extrusion.",
"   </p>",
"   <p>",
"    The small, approximately 1 mm opening in the tympanostomy tube prevents the development of negative pressure in the middle ear. The tube does not \"cure\" otitis media but bypasses the child's immature and poorly functioning eustachian tube to equalize middle ear and atmospheric pressures. Tympanostomy tubes are sometimes called \"pressure equalizing tubes\" or \"ventilation tubes.\" Relapse of AOM or OME when a tube extrudes or is obstructed reflects persistent inadequate function of the child's eustachian tube and should not be interpreted as a surgical \"failure.\"",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TYMPANOSTOMY TUBES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Short- versus long-term",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous designs and materials for tympanostomy tubes, which can be divided into two general types:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Short-term tubes, intended to remain in the TM for 8 to 18 months (",
"      <a class=\"graphic graphic_picture graphicRef71781 \" href=\"UTD.htm?12/42/12962\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Long-term tubes (T-tubes), intended to remain in the TM for more than 15 months (",
"      <a class=\"graphic graphic_picture graphicRef68480 \" href=\"UTD.htm?0/35/561\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Short-term tubes are recommended for most children, because long-term tubes are associated with higher rates of otorrhea and persistent perforation of the TM [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. In theory, the prolonged ventilation provided by a long-term tube is desirable. However, only 30 to 40 percent of children initially treated with short-term tubes require additional tubes or surgery for otitis media. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Tube otorrhea'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H25\">",
"     'Persistent perforation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Tympanostomy tubes stay in position, spanning the eardrum, because they have flanges on the inner and outer surfaces (grommet tubes) (",
"    <a class=\"graphic graphic_picture graphicRef71781 \" href=\"UTD.htm?12/42/12962\">",
"     picture 1",
"    </a>",
"    ), or have shafts that are too long to fit in the middle ear (T-tubes) (",
"    <a class=\"graphic graphic_picture graphicRef68480 \" href=\"UTD.htm?0/35/561\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The duration of tympanostomy tube function is largely dependent on tube design.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grommet tubes with right angles or beveled flanges (Armstrong-type tubes) (",
"      <a class=\"graphic graphic_picture graphicRef71781 \" href=\"UTD.htm?12/42/12962\">",
"       picture 1",
"      </a>",
"      ) normally last about 13 months, with 95 percent extruding between 6 and 18 months [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Tube extrusion'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Shepard-type grommets with an hourglass shape extrude sooner, after a mean duration of about eight months [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Long-shafted tubes (T-tubes) with a large inner flange",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      no outer flange last 20 months or more, and frequently require active removal [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Tube removal'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Earlier extrusion of all types may occur when tubes are inserted into tympanic membranes that have been previously intubated, or have been weakened focally by atrophy or atelectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Tube materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanostomy tube materials are selected for maximum biocompatibility and resistance to clogging and extrusion. The materials include metals (stainless steel, titanium, gold), plastics (silicon elastomer [Silastic], polytetrafluoroethylene [fluoroplastic or Teflon]), and calcium phosphate-based ceramic (hydroxylapatite) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/14\">",
"     14",
"    </a>",
"    ]. Calcium alginate gel tubes that are dissolvable on demand are under development [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No single material has proven superior to the others, but fluoroplastic tubes have been used in most studies of tube safety and efficacy. A variety of modifications have been proposed that are of uncertain value. Silver-oxide impregnated silastic tubes slightly reduce postoperative otorrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/16\">",
"     16",
"    </a>",
"    ], but long-term benefits are poorly studied. Bacterial biofilms can develop on silver-oxide tubes, but ion-bombarded silicone tubes and phosphorylcholine-coated fluoroplastic tubes appear to resist Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. However, rates of postoperative otorrhea, tube blockage, and tube extrusion were no different with phosphorylcholine-coated versus uncoated standard fluoroplastic tubes in a trial of 240 children randomized to receive the coated tube in one ear and the uncoated tube in the other [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/19\">",
"     19",
"    </a>",
"    ]. Polyvinylpyrrolidone coating did not prevent biofilm formation by S. aureus and only decreased P. aeruginosa biofilm formation when the tubes were exposed to saline, but not human blood, in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Tube placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most tubes are placed in the pars tensa of the TM, in any location except the posterosuperior quadrant, which overlies the incus and stapes (",
"    <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef79252 \" href=\"UTD.htm?32/60/33730\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although the anterior half of the drum is generally chosen, location does not correlate with duration of intubation; routine placement in the anterosuperior quadrant, for example, does not prolong intubation compared with placement in the anteroinferior quadrant [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Rarely, tubes are placed between the tympanic annulus and bony ear canal as permanent devices [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR TUBES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanostomy tubes are indicated when long-term ventilation of the middle ear space is desired [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/25\">",
"     25",
"    </a>",
"    ]. Tympanostomy tubes were first used to control the conductive hearing loss associated with middle ear effusion (MEE). As clinicians became familiar with the procedure, applications were expanded to include controlling recurrent AOM and preventing acquired cholesteatoma.",
"   </p>",
"   <p>",
"    Large-scale studies of tympanostomy tube insertion for managing OME",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    AOM have been conducted in various cities of the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. All have shown tube placement to be superior to placebo therapy in selected groups, but the results are not clearly applicable to broader clinical settings.",
"   </p>",
"   <p>",
"    Decisions regarding the placement of tympanostomy tubes should be made on a case-by-case basis. Factors to be considered in the decision include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Efficacy of tube placement in controlling middle ear disease. In a systematic review of studies comparing tympanostomy tubes with myringotomy (without tube placement) or nonsurgical treatment for OME, children with tubes spent 32 percent less time with MEE during the first year of follow-up than children in other groups [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The relative risks of tube placement, including the risks of general anesthesia, weakening of the TM related to surgery, and permanent perforation of the TM, compared to those of no treatment or prophylactic antibiotics (eg, development of antibiotic-resistant pathogens). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Complications and sequelae'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The physical discomfort and medical complications of repeated AOM. The tympanostomy tube permits drainage of infected middle ear fluid and episodes of AOM are less painful than in children without tubes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H27#H27\">",
"       \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Complications and sequelae'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The possible long-term adverse effects of hearing loss related to MEE during the period of rapid speech acquisition in children without tubes. For children with tubes, the middle ear cleft remains fluid free as long as the tubes are patent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/30,31\">",
"       30,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cost to the health care system of tube placement compared to medical management.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific indications for tympanostomy tubes and comparison of tympanostomy tubes with prophylactic antibiotic therapy in children with OME and recurrent AOM are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link\">",
"     \"Acute otitis media in children: Prevention of recurrence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     OM with effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for tympanostomy tube placement in children with otitis media with effusion are discussed separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Recurrent AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for tympanostomy tube placement children with recurrent AOM are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in children: Prevention of recurrence\", section on 'Tympanostomy tubes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once tubes have been placed, follow-up care is required to assure that the tubes are functional, hearing loss has been corrected, and potential complications are properly diagnosed and managed. Follow-up by the operating otolaryngologist, in conjunction with primary care clinicians, is important [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Follow-up schedule",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regular and timely follow-up of all children with tympanostomy tubes is essential for optimum outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. The initial postoperative follow-up visit should be performed by the otolaryngologist to verify the patency and functional status of the tube; this visit should occur within two to four weeks of tube placement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/33\">",
"     33",
"    </a>",
"    ]. Subsequent tube \"check-ups\" are scheduled with the otolaryngologist at four- to six-month intervals, regardless of how well the child is doing. Otolaryngology follow-up should continue until healing of the TM, normal eustachian tube function, and normal hearing have been established [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Referral indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to the otolaryngologist earlier than regularly scheduled follow-up is indicated for [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic, recurrent, bloody, or unresponsive otorrhea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H3#H3\">",
"       \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Tympanostomy tube otorrhea'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Persistent ear pain, deterioration in hearing, or problems with balance.",
"     </li>",
"     <li>",
"      Structural disease or suspected structural disease of the tympanic membrane (eg, perforation, cholesteatoma, retraction at tube site) (",
"      <a class=\"graphic graphic_picture graphicRef59369 \" href=\"UTD.htm?22/20/22848\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Symptomatic children with tympanostomy tube obstruction, particularly if they have preexisting sensorineural hearing loss, or language or developmental delay. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Blocked tubes'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Symptomatic children in whom the tympanostomy tube cannot be visualized.",
"     </li>",
"     <li>",
"      Children with an extruded tympanostomy tube that cannot be removed from the ear canal.",
"     </li>",
"     <li>",
"      Children in whom the tympanostomy tube has migrated into the middle ear space.",
"     </li>",
"     <li>",
"      The tympanostomy tube has been retained for more than two years. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Tube removal'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Audiologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An audiologic evaluation should be performed postoperatively, especially if normal hearing was not established before surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/33,36,37\">",
"     33,36,37",
"    </a>",
"    ]. The purpose of the audiologic assessment is to identify children with persistent conductive or sensorineural hearing loss, independent of OME, who require additional diagnostic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, the tube itself may cause a mild conductive hearing loss (about 10 to 20 dB), which resolves if the tube is occluded temporarily with a paper patch [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/38\">",
"     38",
"    </a>",
"    ]. Extended follow-up of children with tubes, however, shows no evidence of persistent hearing loss directly attributable to intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Assuring tube function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper function of a tympanostomy tube is assured if it is seen to span the eardrum, its lumen is unobstructed, and no MEE is present (",
"    <a class=\"graphic graphic_picture graphicRef76112 \" href=\"UTD.htm?20/58/21410\">",
"     picture 5",
"    </a>",
"    ). When these three features are observed, ventilation of the middle ear through the tube lumen will maintain good hearing and reduce the frequency, duration, and severity of subsequent otitis media episodes.",
"   </p>",
"   <p>",
"    Visualization of a tympanostomy tube may be difficult if the child is struggling, cerumen obstructs the external canal, a long-shafted tube has been used, the tube is oddly angulated, or the tube is placed in the anterosuperior quadrant of the TM (",
"    <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"     figure 1",
"    </a>",
"    ). Adequate cerumen removal and appropriate restraint are needed for any good ear examination. Irrigation and cerumenolytics should be avoided in the presence of a functional tube or perforated eardrum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Otoscopy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=see_link&amp;anchor=H9#H9\">",
"     \"Cerumen\", section on 'Cerumen removal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When tube function cannot be confirmed by visual inspection, pneumatic otoscopy and tympanometry are helpful. If the TM is immobile and translucent on pneumatic otoscopy, with no other signs of MEE, the tube is probably functioning. A flat (type B) tympanogram (",
"    <a class=\"graphic graphic_figure graphicRef67750 \" href=\"UTD.htm?2/34/2595\">",
"     figure 2",
"    </a>",
"    ) with a large volume measurement (static compliance) confirms that a functioning tube (or a perforation) connects the ear canal and middle ear. A peaked (type A or C) tympanogram (",
"    <a class=\"graphic graphic_figure graphicRef67750 \" href=\"UTD.htm?2/34/2595\">",
"     figure 2",
"    </a>",
"    ) suggests a clogged or extruded tube without MEE. A flat tympanogram with small volume measurement indicates a non-functioning tube with MEE [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Blocked tubes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lumen of a tympanostomy tube can become plugged with mucus, blood, or suppurative secretions (",
"    <a class=\"graphic graphic_picture graphicRef76112 \" href=\"UTD.htm?20/58/21410\">",
"     picture 5",
"    </a>",
"    ). Elution profiles of hydrolyzed plugs are most often consistent with mucoid MEE as the obstructing substance [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/41\">",
"     41",
"    </a>",
"    ]. Tube blockage may occur in the immediate post-operative period or after an initial period of patency.",
"   </p>",
"   <p>",
"    Blocked tubes can sometimes be cleared by applying ototopical drops for five to seven days. The United States Food and Drug Administration (FDA) has not approved any medications for clearance of blocked tympanostomy tubes.",
"   </p>",
"   <p>",
"    Otic suspensions are preferable to solutions because their mildly acidic pH is less irritating to the middle-ear mucosa. If the child tastes the drops or complains of stinging (with acidic drops), the drops are likely reaching the middle ear or eustachian tube, indicating that the tympanostomy tube is functioning.",
"   </p>",
"   <p>",
"    The ability of eardrops to clear blocked tympanostomy tubes was demonstrated in a trial in which 110 obstructed tympanostomy tubes in children &ge;27 months of age were randomly assigned to active treatment or observation for 14 days [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/42\">",
"     42",
"    </a>",
"    ]. Patients in the treatment groups filled the ear canal with eardrops (5 percent",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/56/41862?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    or 3 percent",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    ) twice daily and remained supine with the ear upright for five minutes before draining the solution. Clearance of the obstruction occurred in 56 and 71 percent of tubes treated with hydrogen peroxide and sodium bicarbonate, respectively, and in 0 percent of tubes in the observation group. Mild pain developed in 17 percent of patients, but did not prevent them from completing 14 days of therapy.",
"   </p>",
"   <p>",
"    A skilled otolaryngologist can occasionally unclog a plastic grommet by sliding a 3-French metal suction catheter or 18-gauge spinal needle through the tube lumen using the binocular microscope for visualization. This procedure should not be attempted without magnification and is usually unsuccessful with metal or long-shafted tubes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5227969\">",
"    <span class=\"h2\">",
"     Postoperative antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data on the use of oral antibiotics in the immediate postoperative setting. If a new AOM is noted at the time of surgery, the author cultures the middle ear contents at the time of tube placement and follows a treatment plan similar to that suggested for acute tympanostomy tube otorrhea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H10#H10\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Acute tympanostomy tube otorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of prophylactic eardrops (including antibiotic drops) during the postoperative period to prevent tympanostomy tube otorrhea is also discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H5#H5\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Prevention of tympanostomy tube otorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Episodes of AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanostomy tubes reduce the frequency of AOM, but do not prevent all episodes. The average child has at least one episode of AOM in the year after tube insertion, and some children have numerous episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/43\">",
"     43",
"    </a>",
"    ]. Significant episodes of AOM routinely cause purulent drainage from the tube. This often presents as otorrhea visible emanating from the ear canal, but it may be subtle, apparent only on otoscopy. Some of these episodes are painful; many have minimal discomfort. Most occur on the third or fourth day of a cold [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/44\">",
"     44",
"    </a>",
"    ]. In older children, otorrhea may follow repeated water contamination without an antecedent upper respiratory infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H19#H19\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H3#H3\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Tympanostomy tube otorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5227941\">",
"    <span class=\"h2\">",
"     Water precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for water precautions (eg, the use of ear plugs, swimming caps, or antibiotic-containing eardrops) in children with tympanostomy tubes is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H9#H9\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Water precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Tube extrusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrusion of short-term tubes is initiated by the continual shedding of squamous debris from the epithelium of the TM; the migrating keratin from the TM accumulates between the surface epithelium and the outer flange of the tube [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/23\">",
"     23",
"    </a>",
"    ]. Small amounts of keratin debris adjacent to a functioning tube are a normal and expected finding. The debris requires no attention unless it obstructs the tube lumen or causes a local inflammatory response (granulation tissue).",
"   </p>",
"   <p>",
"    As debris accumulates under the outer flange of a grommet tube, the pressure causes the flange to lift up from the surface of the TM (",
"    <a class=\"graphic graphic_picture graphicRef66173 \" href=\"UTD.htm?40/38/41583\">",
"     picture 6",
"    </a>",
"    ). The inner flange of the tube becomes visible as it presses against the eardrum, and begins to extrude as the tube tips posteriorly. When both flanges are clearly in view, extrusion is complete (",
"    <a class=\"graphic graphic_picture graphicRef74566 \" href=\"UTD.htm?36/51/37682\">",
"     picture 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Long-shafted tubes (T-tubes) are designed without an outer flange, which prevents the above sequence of events from occurring. Migrating epithelium may accumulate along the length of the shaft during the months following insertion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Tube removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small percentage of short-term tubes, and many long-term tubes, do not extrude spontaneously and require surgical removal; the overall risk of failed extrusion is 5 to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/46\">",
"     46",
"    </a>",
"    ]. A child who fails to extrude one of the bilateral tympanostomy tubes has an increased risk of nonextrusion of the other tube; the risk of nonextrusion also appears to be increased in the siblings of a child with failed extrusion, suggesting a possible genetic mechanism, perhaps related to wound healing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most otolaryngologists wait at least two to three years before considering the surgical removal of an uncomplicated short-term (grommet) tube and four years before considering the surgical removal of a long-term tube [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/34,47,48\">",
"     34,47,48",
"    </a>",
"    ]. The rates of persistent perforation are increased when tubes are left in place for longer than three years than when tubes are removed electively before three years (15 versus 3 percent in one retrospective analysis) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Complications and sequelae'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Flexible silicone tubes may occasionally be removed in the office setting. However, general anesthesia is usually necessary for removal of tympanostomy tubes made of rigid materials. An additional advantage of anesthesia is that epithelial debris or ingrowth can be removed from the perforation edges under microscopic visualization (",
"    <a class=\"graphic graphic_picture graphicRef75608 \" href=\"UTD.htm?9/5/9296\">",
"     picture 8",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for surgical removal of tympanostomy tubes are well described [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/47,48,50\">",
"     47,48,50",
"    </a>",
"    ]. Children aged six years or older are the best candidates for tube removal because otitis media declines rapidly as the immune system and eustachian tube reach maturity. Younger children, however, also may benefit from removal based on the frequency and severity of morbidity associated with tympanostomy tubes that have been in place for longer than two to three years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Complications and sequelae'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Specific indications for tube removal include [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/47,48,50\">",
"     47,48,50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure of spontaneous tube extrusion after three years.",
"     </li>",
"     <li>",
"      Retained unilateral tympanostomy tube in a child aged six years or older, when the contralateral TM is intact and has been free of AOM or OME for at least one year [",
"      <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/51-53\">",
"       51-53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Retained bilateral tympanostomy tubes in a child with normal eustachian tube function, resulting from growth, medical therapy, or surgery (adenoidectomy or cleft palate repair).",
"     </li>",
"     <li>",
"      Frequent recurrent otorrhea despite medical management, particularly in older children with longstanding tubes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link\">",
"       \"Prevention and management of tympanostomy tube otorrhea in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic otorrhea, unresponsive to topical and systemic antimicrobials. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H3#H3\">",
"       \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Tympanostomy tube otorrhea'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tube-associated granulation tissue or granuloma that does not respond to topical therapy or debridement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Myringoplasty with a paper-patch [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/48\">",
"     48",
"    </a>",
"    ], steri-strip [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/50,54\">",
"     50,54",
"    </a>",
"    ], or silastic sheeting [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/55\">",
"     55",
"    </a>",
"    ] (or gelfilm) at the time of tympanostomy tube removal may increase the rate of perforation closure. Although not all children require myringoplasty when tubes are removed, reasonable indications include long-term tubes, a history of multiple prior intubations, and short-term tubes with epithelial ingrowth or an intubation period of two years or longer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COMPLICATIONS AND SEQUELAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A child with middle ear disease severe enough to require tympanostomy tubes remains at risk for recurrent infection, persistent MEE, and for several late complications of tube placement. Complications and sequelae of tympanostomy tubes and their frequency in a meta-analysis of tympanostomy tube sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"     56",
"    </a>",
"    ] include [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tympanostomy tube otorrhea (16 percent of patients within two weeks of placement, 26 percent of patients more than two weeks after placement). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link\">",
"       \"Prevention and management of tympanostomy tube otorrhea in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Occlusion of tubes (7 percent of ears). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Blocked tubes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Premature extrusion (4 percent of ears).",
"     </li>",
"     <li>",
"      Medial displacement of tubes (",
"      <a class=\"graphic graphic_picture graphicRef53611 \" href=\"UTD.htm?29/44/30415\">",
"       picture 9",
"      </a>",
"      ) (0.5 percent of ears).",
"     </li>",
"     <li>",
"      Persistent perforation (2 percent of ears with short-term tubes, 16 percent of ears with long-term tubes).",
"     </li>",
"     <li>",
"      Tympanosclerosis, also called myringosclerosis (32 percent of ears).",
"     </li>",
"     <li>",
"      Focal atrophy of the TM at the site of insertion, which increases the risk of retraction pockets and cholesteatoma (25 percent of ears).",
"     </li>",
"     <li>",
"      Retraction pocket (",
"      <a class=\"graphic graphic_picture graphicRef82650 \" href=\"UTD.htm?42/12/43200\">",
"       picture 10",
"      </a>",
"      ) (3 percent of ears).",
"     </li>",
"     <li>",
"      Cholesteatoma (0.8 percent of ears with short-term tubes, 1.4 percent with long-term tubes). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"       \"Cholesteatoma in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although most of these complications are uncommon, early detection and management are necessary to reduce long-term morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Tube otorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevention and management of tube otorrhea are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link\">",
"     \"Prevention and management of tympanostomy tube otorrhea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Persistent perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent perforation (",
"    <a class=\"graphic graphic_picture graphicRef65036 \" href=\"UTD.htm?0/50/800\">",
"     picture 11",
"    </a>",
"    ) after tube extrusion is related to tube type, duration of intubation, and baseline structural integrity of the TM [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/10,56,60,61\">",
"     10,56,60,61",
"    </a>",
"    ]. Mean perforation rates for short- versus long-term tubes are 2.2 versus 16.6 percent, respectively, with a 3.5-fold increase in relative risk for the latter [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one review of 2604 ears in which tympanostomy tubes were placed for recurrent AOM or otitis media with effusion, the overall rate of persistent perforations was 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/61\">",
"     61",
"    </a>",
"    ]. The rate of persistent perforation was increased in the following groups:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Children younger than five years compared to those older than five years (6 versus 4 percent)",
"     </li>",
"     <li>",
"      Children with recurrent AOM compared to those with OME (16 versus 2 percent)",
"     </li>",
"     <li>",
"      Children who received long-term tubes compared to those who received short-term tubes (15 versus 2 percent)",
"     </li>",
"     <li>",
"      Children with &ge;2 compared to &le;1 previous tube placements (14 versus 3 percent)",
"     </li>",
"     <li>",
"      Children with &ge;3 compared to no episodes of postoperative otorrhea (11 versus 2 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of persistent perforation is made clinically with otoscopy (",
"    <a class=\"graphic graphic_picture graphicRef65036 \" href=\"UTD.htm?0/50/800\">",
"     picture 11",
"    </a>",
"    ). Pneumatic otoscopy demonstrates an immobile TM. Tympanometry that demonstrates a flat (type B) tympanogram (",
"    <a class=\"graphic graphic_figure graphicRef67750 \" href=\"UTD.htm?2/34/2595\">",
"     figure 2",
"    </a>",
"    ) with a large volume measurement confirms the diagnosis.",
"   </p>",
"   <p>",
"    A 6- to 12-month observation period is recommended before surgical closure of persistent perforation because most post-intubation perforations close spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent small, central perforations may be plugged with adipose tissue harvested from the posterior aspect of the lobule (80 to 90 percent success) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. The best results are achieved when the child has been free of active middle ear disease for one year, to avoid having to re-intubate a TM that has been grafted successfully [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/65-67\">",
"     65-67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Tympanosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanostomy tubes are associated with structural changes of the TM [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Approximately 32 percent of TMs (range 7 to 64 percent) develop asymptomatic whitish plaques of calcium and phosphate crystals (tympanosclerosis) (",
"    <a class=\"graphic graphic_picture graphicRef58460 \" href=\"UTD.htm?33/59/34751\">",
"     picture 12",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"     56",
"    </a>",
"    ]. For every 3.3 children who receive tubes, one additional case of tympanosclerosis occurs compared to non-intubated otitis media controls. The plaques may be localized or diffuse, and are of uncertain etiology. Boys are affected more often than girls [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/70\">",
"     70",
"    </a>",
"    ], and larger plaques are associated with multiple intubations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of tympanosclerosis is made clinically. Otoscopy demonstrates whitish plaques on the TM (",
"    <a class=\"graphic graphic_picture graphicRef58460 \" href=\"UTD.htm?33/59/34751\">",
"     picture 12",
"    </a>",
"    ); pneumatic otoscopy may demonstrate decreased or absent mobility. Such plaques are firm and contained within the middle layer of the drum, unlike cholesteatomas, which are soft and occupy the middle ear space. Otomicroscopy with palpation or computed tomography may be necessary to differentiate these disorders.",
"   </p>",
"   <p>",
"    Tympanosclerosis associated with tympanostomy tube placement rarely requires treatment. Although the plaques may theoretically cause hearing loss if they involve the ossicles, this phenomenon has not been associated with tympanostomy tubes. The hearing impairment caused by tympanosclerosis is less than 0.5 dB, which is inconsequential [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Focal atrophy of TM",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a tympanostomy tube has extruded, the resultant perforation (about 1 to 2 mm diameter) heals as a dimer composed of only the squamous and mucosal layers of the TM (the middle fibrous layer of the TM does not regenerate) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/72\">",
"     72",
"    </a>",
"    ]. This potential area of weakness is more susceptible to subsequent retraction or perforation (",
"    <a class=\"graphic graphic_picture graphicRef59369 \" href=\"UTD.htm?22/20/22848\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Focal atrophy or retraction at the site of a prior tube occurs in approximately 25 percent of ears (range: 2 to 75 percent), and pars tensa retraction pockets in approximately 3 percent of previously intubated ears (range: 0 to 23) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Focal weakening of the TM is usually non-progressive, and tympanoplasty is rarely required. Generalized atrophy or TM collapse (atelectasis) (",
"    <a class=\"graphic graphic_picture graphicRef78843 \" href=\"UTD.htm?4/0/4098\">",
"     picture 13",
"    </a>",
"    ) is caused by poor eustachian tube function, not by prior intubation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Cholesteatoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cholesteatoma is an accumulation of desquamating epithelium within the middle ear that may grow to envelop the ossicles and result in conductive hearing loss and destruction of the ossicular chain. Because acquired cholesteatoma is a complication of recurrent AOM, the placement of tympanostomy tubes may have an overall protective effect on cholesteatoma formation in children with recurrent AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/73\">",
"     73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"     \"Cholesteatoma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, acquired cholesteatoma also can occur as a complication of tympanostomy tube placement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/74-78\">",
"     74-78",
"    </a>",
"    ]. The risk of cholesteatoma formation is increased with long-term tubes compared with short-term tubes. In one meta-analysis of tympanostomy tube sequelae, cholesteatoma occurred in 0.8 percent of children with short-term tubes and 1.4 percent of children with long-term tubes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"     56",
"    </a>",
"    ]. In a large retrospective cohort, cholesteatoma occurred in 1 percent of children who underwent tympanostomy tube insertion. The risk of cholesteatoma was increased in children who underwent multiple tympanostomy tube insertions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retraction pockets are the first step in the genesis of an acquired cholesteatoma (",
"    <a class=\"graphic graphic_picture graphicRef82650 \" href=\"UTD.htm?42/12/43200\">",
"     picture 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/56/3978/abstract/79\">",
"     79",
"    </a>",
"    ]. If squamous debris begins to collect in a deep- or narrow-mouthed retraction pocket and egress of the material is obstructed, granulation tissue and secondary infection ensue. Enlargement of the collection may result in erosion of the ossicular chain, mastoid air cells, and external auditory canal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/9/20626?source=see_link\">",
"       \"Patient information: Ear tubes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The placement of tympanostomy tubes permits adequate ventilation of the middle ear, circumventing the child's immature and poorly functioning eustachian tube. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tympanostomy tubes are indicated when long-term ventilation of the middle ear space is desired. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Indications for tubes'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link&amp;anchor=H21#H21\">",
"       \"Acute otitis media in children: Prevention of recurrence\", section on 'Tympanostomy tubes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Otolaryngology follow-up after tympanostomy tube placement typically occurs at four- to six-month intervals. Otolaryngology follow-up continues until at least one year after extrusion or removal of tubes and healing of the TM, normal eustachian tube function, and normal hearing have been established. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Follow-up schedule'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Referral to the otolaryngologist earlier than regularly scheduled follow-up is indicated for (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Referral indications'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Chronic, recurrent, or bloody otorrhea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=see_link&amp;anchor=H3#H3\">",
"       \"Prevention and management of tympanostomy tube otorrhea in children\", section on 'Tympanostomy tube otorrhea'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Persistent ear pain, deterioration in hearing, or problems with balance.",
"     </li>",
"     <li>",
"      Structural disease or suspected structural disease of the tympanic membrane.",
"     </li>",
"     <li>",
"      Children with symptoms in whom the tube is obstructed or cannot be visualized. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Blocked tubes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An extruded tube that cannot be removed from the ear canal.",
"     </li>",
"     <li>",
"      A tube that has migrated into the middle ear space.",
"     </li>",
"     <li>",
"      The tube has been retained for more than two years. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Tube removal'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proper function of a tympanostomy tube is assured if it is seen to span the eardrum, its lumen is unobstructed, and no middle ear effusion is present (",
"      <a class=\"graphic graphic_picture graphicRef76112 \" href=\"UTD.htm?20/58/21410\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Assuring tube function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications and sequelae of tympanostomy tubes include persistent perforation of the tympanic membrane (",
"      <a class=\"graphic graphic_picture graphicRef65036 \" href=\"UTD.htm?0/50/800\">",
"       picture 11",
"      </a>",
"      ), tube obstruction (",
"      <a class=\"graphic graphic_picture graphicRef76112 \" href=\"UTD.htm?20/58/21410\">",
"       picture 5",
"      </a>",
"      ), tympanosclerosis (",
"      <a class=\"graphic graphic_picture graphicRef58460 \" href=\"UTD.htm?33/59/34751\">",
"       picture 12",
"      </a>",
"      ), focal atrophy of the tympanic membrane (",
"      <a class=\"graphic graphic_picture graphicRef59369 \" href=\"UTD.htm?22/20/22848\">",
"       picture 4",
"      </a>",
"      ), and cholesteatoma. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Complications and sequelae'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/1\">",
"      Derkay CS. Pediatric otolaryngology procedures in the United States: 1977-1987. Int J Pediatr Otorhinolaryngol 1993; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/2\">",
"      Kogan MD, Overpeck MD, Hoffman HJ, Casselbrant ML. Factors associated with tympanostomy tube insertion among preschool-aged children in the United States. Am J Public Health 2000; 90:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/3\">",
"      Myer CM 3rd, France A. Ventilation tube placement in a managed care population. Arch Otolaryngol Head Neck Surg 1997; 123:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/4\">",
"      Bluestone CD, Paradise JL, Beery QC. Physiology of the eustachian tube in the pathogenesis and management of middle ear effusions. Laryngoscope 1972; 82:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/5\">",
"      Berger G. Nature of spontaneous tympanic membrane perforation in acute otitis media in children. J Laryngol Otol 1989; 103:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/6\">",
"      Alberti PW. Myringotomy and ventilating tubes in the 19th century. Laryngoscope 1974; 84:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/7\">",
"      ARMSTRONG BW. A new treatment for chronic secretory otitis media. AMA Arch Otolaryngol 1954; 59:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/8\">",
"      Weigel MT, Parker MY, Goldsmith MM, et al. A prospective randomized study of four commonly used tympanostomy tubes. Laryngoscope 1989; 99:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/9\">",
"      von Schoenberg M, Wengraf CL, Gleeson M. Results of middle ear ventilation with Goode's tubes. Clin Otolaryngol Allied Sci 1989; 14:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/10\">",
"      Goode RL. Long-term middle ear ventilation with T tubes: the perforation problem. Otolaryngol Head Neck Surg 1996; 115:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/11\">",
"      Hussain SS. Extrusion rate of Shah and Shepard ventilation tubes in children. Ear Nose Throat J 1992; 71:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/12\">",
"      Moore PJ. Ventilation tube duration versus design. Ann Otol Rhinol Laryngol 1990; 99:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/13\">",
"      Leopold DA, McCabe BF. Factors influencing tympanostomy tube function and extrusion: a study of 1,127 ears. Otolaryngol Head Neck Surg 1980; 88:447.",
"     </a>",
"    </li>",
"    <li>",
"     Soderberg O, Hellstrom SO. Effects of different tympanostomy tubes (Teflon and stainless steel) on the tympanic membrane structures. In: Recent advances in otitis media, Lim DJ, Bluestone CD, Klein JO, Nelson JD (Eds), BC Decker Inc, Toronto 1988. p.280.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/15\">",
"      Sherman EG, Antonelli PJ, Tran-Son-Tay R. Development of a calcium alginate tympanostomy tube. Laryngoscope 2010; 120:2473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/16\">",
"      Gourin CG, Hubbell RN. Otorrhea after insertion of silver oxide-impregnated silastic tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1999; 125:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/17\">",
"      Saidi IS, Biedlingmaier JF, Whelan P. In vivo resistance to bacterial biofilm formation on tympanostomy tubes as a function of tube material. Otolaryngol Head Neck Surg 1999; 120:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/18\">",
"      Berry JA, Biedlingmaier JF, Whelan PJ. In vitro resistance to bacterial biofilm formation on coated fluoroplastic tympanostomy tubes. Otolaryngol Head Neck Surg 2000; 123:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/19\">",
"      Hong P, Smith N, Johnson LB, Corsten G. A randomized double-blind controlled trial of phosphorylcholine-coated tympanostomy tube versus standard tympanostomy tube in children with recurrent acute and chronic otitis media. Laryngoscope 2011; 121:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/20\">",
"      Antonelli PJ, Sampson EM, Ojano-Dirain C. Biofilm formation on silicone tympanostomy tubes with polyvinylpyrrolidone coating. Arch Otolaryngol Head Neck Surg 2011; 137:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/21\">",
"      April MM, Portella RR, Orobello PW Jr, Naclerio RM. Tympanostomy tube insertion: anterosuperior vs. anteroinferior quadrant. Otolaryngol Head Neck Surg 1992; 106:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/22\">",
"      Hern JD, Jonathan DA. Insertion of ventilation tubes: does the site matter? Clin Otolaryngol Allied Sci 1999; 24:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/23\">",
"      van Baarle PW, Wentges RT. Extrusion of transtympanic ventilating tubes, relative to the site of insertion. ORL J Otorhinolaryngol Relat Spec 1975; 37:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/24\">",
"      Jahn AF. Middle ear ventilation with HydroxylVent tube: review of the initial series. Otolaryngol Head Neck Surg 1993; 108:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/25\">",
"      Bluestone CD, Klein JO, Gates GA. 'Appropriateness' of tympanostomy tubes. Setting the record straight. Arch Otolaryngol Head Neck Surg 1994; 120:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/26\">",
"      Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992; 11:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/27\">",
"      Gates GA, Avery CA, Cooper JC Jr, Prihoda TJ. Chronic secretory otitis media: effects of surgical management. Ann Otol Rhinol Laryngol Suppl 1989; 138:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/28\">",
"      Giebink GS. Preventing otitis media. Ann Otol Rhinol Laryngol Suppl 1994; 163:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/29\">",
"      Browning GG, Rovers MM, Williamson I, et al. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2010; :CD001801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/30\">",
"      Principi N, Marchisio P, Massironi E, et al. Prophylaxis of recurrent acute otitis media and middle-ear effusion. Comparison of amoxicillin with sulfamethoxazole and trimethoprim. Am J Dis Child 1989; 143:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/31\">",
"      Varsano I, Volovitz B, Mimouni F. Sulfisoxazole prophylaxis of middle ear effusion and recurrent acute otitis media. Am J Dis Child 1985; 139:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/32\">",
"      Follow-up management of children with tympanostomy tubes. Pediatrics 2002; 109:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/33\">",
"      Isaacson G, Rosenfeld RM. Care of the child with tympanostomy tubes: a visual guide for the pediatrician. Pediatrics 1994; 93:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/34\">",
"      Derkay CS, Carron JD, Wiatrak BJ, et al. Postsurgical follow-up of children with tympanostomy tubes: results of the American Academy of Otolaryngology-Head and Neck Surgery Pediatric Otolaryngology Committee National Survey. Otolaryngol Head Neck Surg 2000; 122:313.",
"     </a>",
"    </li>",
"    <li>",
"     Sederberg-Olsen JF, Sederberg-Olsen AE, Jensen AM. Late sequelae related to treatment with ventilation tubes for secretory otitis media in ENT practice. In: Recent advances in otitis media, Mogi G, Honjo I, Tetsuo I, Takasaka T (Eds), Kugler Publications, Amsterdam 1994. p.843.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/36\">",
"      Manning SC, Brown OE, Roland PS, Phillips DL. Incidence of sensorineural hearing loss in patients evaluated for tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1994; 120:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/37\">",
"      Emery M, Weber PC. Hearing loss due to myringotomy and tube placement and the role of preoperative audiograms. Arch Otolaryngol Head Neck Surg 1998; 124:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/38\">",
"      Estrem SA, Batra PS. Conductive hearing loss associated with pressure equalization tubes. Otolaryngol Head Neck Surg 2000; 122:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/39\">",
"      Valtonen HJ, Qvarnberg YH, Nuutinen J. Otological and audiological outcomes five years after tympanostomy in early childhood. Laryngoscope 2002; 112:669.",
"     </a>",
"    </li>",
"    <li>",
"     Bluestone CD, Klein JO. Otitis media in infants and children, WB Saunders Co, Philadelphia 1988. p.89.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/41\">",
"      Westine JG, Giannoni CM, Gajewski B, Antonelli PJ. Opening plugged tympanostomy tubes. Laryngoscope 2002; 112:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/42\">",
"      Spraggs PD, Robinson PJ, Ryan R, et al. A prospective randomised trial of the use of sodium bicarbonate and hydrogen peroxide ear drops to clear a blocked tympanostomy tube. Int J Pediatr Otorhinolaryngol 1995; 31:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/43\">",
"      Mandel EM, Casselbrant ML, Kurs-Lasky M. Acute otorrhea: bacteriology of a common complication of tympanostomy tubes. Ann Otol Rhinol Laryngol 1994; 103:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/44\">",
"      Ruohola A, Heikkinen T, Jero J, et al. Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes. J Pediatr 1999; 134:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/45\">",
"      Schneider ML. Bacteriology of otorrhea from tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1989; 115:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/46\">",
"      Azadarmaki R, Gaughan JP, Isaacson G. Failed tube extrusion is not a random event in children or their siblings. Laryngoscope 2008; 118:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/47\">",
"      Cunningham MJ, Eavey RD, Krouse JH, Kiskaddon RM. Tympanostomy tubes: experience with removal. Laryngoscope 1993; 103:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/48\">",
"      Pribitkin EA, Handler SD, Tom LW, et al. Ventilation tube removal. Indications for paper patch myringoplasty. Arch Otolaryngol Head Neck Surg 1992; 118:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/49\">",
"      Lentsch EJ, Goudy S, Ganzel TM, et al. Rate of persistent perforation after elective tympanostomy tube removal in pediatric patients. Int J Pediatr Otorhinolaryngol 2000; 54:143.",
"     </a>",
"    </li>",
"    <li>",
"     Bluestone CD. Otologic surgical procedures. In: Atlas of pediatric otolaryngology, Bluestone CD, Stool SE (Eds), WB Saunders Co, Philadelphia 1995. p.38.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/51\">",
"      Bluestone CD, Beery QC, Cantekin EI, Paradise JL. Eustachian tube ventilatory function in relation to cleft palate. Ann Otol Rhinol Laryngol 1975; 84:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/52\">",
"      Smith TL, DiRuggiero DC, Jones KR. Recovery of eustachian tube function and hearing outcome in patients with cleft palate. Otolaryngol Head Neck Surg 1994; 111:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/53\">",
"      Smith LK, Gubbels SP, MacArthur CJ, Milczuk HA. The effect of the palatoplasty method on the frequency of ear tube placement. Arch Otolaryngol Head Neck Surg 2008; 134:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/54\">",
"      Saito T, Iwaki E, Kohno Y, et al. Prevention of persistent ear drum perforation after long-term ventilation tube treatment for otitis media with effusion in children. Int J Pediatr Otorhinolaryngol 1996; 38:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/55\">",
"      Courteney-Harris RG, Ford GR, Ganiwalla TM, Mangat KS. Closure of tympanic membrane perforation after the removal of Goode-type tympanostomy tubes: the use of silastic sheeting. J Laryngol Otol 1992; 106:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/56\">",
"      Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001; 124:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/57\">",
"      DeRosa J, Grundfast KM. Surgical management of otitis media. Pediatr Ann 2002; 31:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/58\">",
"      Stenstrom R, Pless IB, Bernard P. Hearing thresholds and tympanic membrane sequelae in children managed medically or surgically for otitis media with effusion. Arch Pediatr Adolesc Med 2005; 159:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/59\">",
"      Vaile L, Williamson T, Waddell A, Taylor G. Interventions for ear discharge associated with grommets (ventilation tubes). Cochrane Database Syst Rev 2006; :CD001933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/60\">",
"      Nichols PT, Ramadan HH, Wax MK, Santrock RD. Relationship between tympanic membrane perforations and retained ventilation tubes. Arch Otolaryngol Head Neck Surg 1998; 124:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/61\">",
"      Golz A, Netzer A, Joachims HZ, et al. Ventilation tubes and persisting tympanic membrane perforations. Otolaryngol Head Neck Surg 1999; 120:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/62\">",
"      Koch WM, Friedman EM, McGill TJ, Healy GB. Tympanoplasty in children. The Boston Children's Hospital experience. Arch Otolaryngol Head Neck Surg 1990; 116:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/63\">",
"      Gross CW, Bassila M, Lazar RH, et al. Adipose plug myringoplasty: an alternative to formal myringoplasty techniques in children. Otolaryngol Head Neck Surg 1989; 101:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/64\">",
"      Deddens AE, Muntz HR, Lusk RP. Adipose myringoplasty in children. Laryngoscope 1993; 103:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/65\">",
"      Bluestone CD, Cantekin EI, Douglas GS. Eustachian tube function related to the results of tympanoplasty in children. Laryngoscope 1979; 89:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/66\">",
"      Manning SC, Cantekin EI, Kenna MA, Bluestone CD. Prognostic value of eustachian tube function in pediatric tympanoplasty. Laryngoscope 1987; 97:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/67\">",
"      Lin AC, Messner AH. Pediatric tympanoplasty: factors affecting success. Curr Opin Otolaryngol Head Neck Surg 2008; 16:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/68\">",
"      Tos M, Stangerup SE. Hearing loss in tympanosclerosis caused by grommets. Arch Otolaryngol Head Neck Surg 1989; 115:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/69\">",
"      Pichichero ME, Berghash LR, Hengerer AS. Anatomic and audiologic sequelae after tympanostomy tube insertion or prolonged antibiotic therapy for otitis media. Pediatr Infect Dis J 1989; 8:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/70\">",
"      Koc A, Uneri C. Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube. Eur Arch Otorhinolaryngol 2001; 258:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/71\">",
"      Friedman EM, Sprecher RC, Simon S, Dunn JK. Quantitation and prevalence of tympanosclerosis in a pediatric otolaryngology clinic. Int J Pediatr Otorhinolaryngol 2001; 60:205.",
"     </a>",
"    </li>",
"    <li>",
"     Schuknecht HF. Pathology of the ear, Harvard University Press, Cambridge, MA 1974. p.256.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/73\">",
"      Rakover Y, Keywan K, Rosen G. Comparison of the incidence of cholesteatoma surgery before and after using ventilation tubes for secretory otitis media. Int J Pediatr Otorhinolaryngol 2000; 56:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/74\">",
"      Klingensmith MR, Strauss M, Conner GH. A comparison of retention and complication rates of large-bore (Paparella II) and small-bore middle ear ventilating tubes. Otolaryngol Head Neck Surg 1985; 93:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/75\">",
"      Mawson SR, Fagan P. Tympanic effusions in children. Long-term results of treatment by myringotomy, aspiration and indwelling tubes (grommets). J Laryngol Otol 1972; 86:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/76\">",
"      Pappas JJ. Middle ear ventilation tubes. Laryngoscope 1974; 84:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/77\">",
"      Tos M, Stangerup SE, Larsen P. Dynamics of eardrum changes following secretory otitis. A prospective study. Arch Otolaryngol Head Neck Surg 1987; 113:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/78\">",
"      Spilsbury K, Miller I, Semmens JB, Lannigan FJ. Factors associated with developing cholesteatoma: a study of 45,980 children with middle ear disease. Laryngoscope 2010; 120:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/56/3978/abstract/79\">",
"      Grimes ER, Isaacson G. The mechanical reduction of early acquired cholesteatomas in children: indications and limitations. Ear Nose Throat J 2006; 85:252, 254, 256.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6305 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-3DA446CC7F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3978=[""].join("\n");
var outline_f3_56_3978=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TYMPANOSTOMY TUBES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Short- versus long-term",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Tube materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Tube placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INDICATIONS FOR TUBES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      OM with effusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Recurrent AOM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Follow-up schedule",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Referral indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Audiologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Assuring tube function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Blocked tubes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5227969\">",
"      Postoperative antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Episodes of AOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5227941\">",
"      Water precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Tube extrusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Tube removal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COMPLICATIONS AND SEQUELAE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Tube otorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Persistent perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Tympanosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Focal atrophy of TM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/6305\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6305|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/31/26099\" title=\"figure 1\">",
"      Tympanic membrane anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/34/2595\" title=\"figure 2\">",
"      Tympanogram classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6305|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/42/12962\" title=\"picture 1\">",
"      Short term tubes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/35/561\" title=\"picture 2\">",
"      Long term tubes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/60/33730\" title=\"picture 3\">",
"      Tympanostomy tube placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/20/22848\" title=\"picture 4\">",
"      Focal atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/58/21410\" title=\"picture 5\">",
"      Tube patency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/38/41583\" title=\"picture 6\">",
"      Squamous debris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/51/37682\" title=\"picture 7\">",
"      Tube extrusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/5/9296\" title=\"picture 8\">",
"      Retained TT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/44/30415\" title=\"picture 9\">",
"      Tube in middle ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/12/43200\" title=\"picture 10\">",
"      TM retraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/50/800\" title=\"picture 11\">",
"      Persistent perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/59/34751\" title=\"picture 12\">",
"      Tympanosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/0/4098\" title=\"picture 13\">",
"      TM atelectasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=related_link\">",
"      Acute otitis media in children: Prevention of recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=related_link\">",
"      Cerumen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/9/20626?source=related_link\">",
"      Patient information: Ear tubes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36457?source=related_link\">",
"      Prevention and management of tympanostomy tube otorrhea in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_56_3979="T cell co-stimulator molecules";
var content_f3_56_3979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F62994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F62994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Co-stimulator molecules",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        CD28 and B7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B7-1 &gt; B7-2 (CD80)",
"       </td>",
"       <td>",
"        eg, Dendritic cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B7h (GL50, ICOS-L)",
"       </td>",
"       <td>",
"        eg, Fibroblasts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PD-1 and PD-1L",
"       </td>",
"       <td>",
"        eg, Hematopoietic cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD40 and CD40L",
"       </td>",
"       <td>",
"        eg, B cells, Fibroblasts, thyroid cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ICAM and LFA-1",
"       </td>",
"       <td>",
"        eg, Thyroid cells",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3979=[""].join("\n");
var outline_f3_56_3979=null;
var title_f3_56_3980="Fetal reticulocyte count by GA";
var content_f3_56_3980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Reticulocyte count, 10",
"    <sup>",
"     12",
"    </sup>",
"    /L",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        GA",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        0.15",
"       </td>",
"       <td>",
"        0.33",
"       </td>",
"       <td>",
"        0.73",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        0.13",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        0.66",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        0.12",
"       </td>",
"       <td>",
"        0.27",
"       </td>",
"       <td>",
"        0.60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        0.11",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        0.55",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        0.10",
"       </td>",
"       <td>",
"        0.22",
"       </td>",
"       <td>",
"        0.50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.09",
"       </td>",
"       <td>",
"        0.20",
"       </td>",
"       <td>",
"        0.46",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        0.08",
"       </td>",
"       <td>",
"        0.19",
"       </td>",
"       <td>",
"        0.41",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        0.08",
"       </td>",
"       <td>",
"        0.17",
"       </td>",
"       <td>",
"        0.38",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        0.07",
"       </td>",
"       <td>",
"        0.15",
"       </td>",
"       <td>",
"        0.35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        0.06",
"       </td>",
"       <td>",
"        0.14",
"       </td>",
"       <td>",
"        0.32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        0.06",
"       </td>",
"       <td>",
"        0.13",
"       </td>",
"       <td>",
"        0.29",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3980=[""].join("\n");
var outline_f3_56_3980=null;
var title_f3_56_3981="Response definitions CML";
var content_f3_56_3981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Response by type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Definitions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"5\">",
"        Complete (CHR)",
"       </td>",
"       <td>",
"        WBC &lt;10 x 10",
"        <sup>",
"         9",
"        </sup>",
"        /L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basophils &lt;5 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No myelocytes, promyelocytes, myeloblasts in the differential",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelet count &lt;450 x 10",
"        <sup>",
"         9",
"        </sup>",
"        /L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spleen nonpalpable",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cytogenetic*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Complete (CCgR)",
"       </td>",
"       <td>",
"        No Ph+ metaphases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Partial (PCgR)",
"       </td>",
"       <td>",
"        1 percent to 35 percent Ph+ metaphases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Major (MCgR)",
"       </td>",
"       <td>",
"        CCgR plus PCgR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Minor (mCgR)",
"       </td>",
"       <td>",
"        36 percent to 65 percent Ph+ metaphases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Minimal (minCgR)",
"       </td>",
"       <td>",
"        66 percent to 95 percent Ph+ metaphases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        None (noCgR)",
"       </td>",
"       <td>",
"        &gt;95 percent Ph+ metaphases",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Molecular",
"        <span class=\"small\">",
"         <sup>",
"          &bull;",
"         </sup>",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Complete (CMolR)",
"       </td>",
"       <td>",
"        Undetectable BCR-ABL mRNA transcripts by real time quantitative and/or nested PCR in two consecutive blood samples of adequate quality (sensitivity &gt;10",
"        <sup>",
"         4",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Major (MMolR)",
"       </td>",
"       <td>",
"        Ratio of BCR-ABL to ABL (or other housekeeping genes) &le;0.1 percent on the international scale",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CHR: complete hematologic response; CCgR: complete cytogenic response; PCgR: partial cytogenetic response; Ph+: Philadelphia chromosome positive; MCgR: major cytogenetic response; minCgR: minor cytogenetic response; noCgR: no cytogenetic response; CMolR: complete molecular response; PCR: polymerase chain reaction; MMolR: major molecular response.",
"     <br>",
"      * The CCgR requires the karyotyping of at least 20 metaphase cells from the bone marrow aspirate. If marrow cell metaphases cannot be obtained or evaluated by chromosome banding analysis, the definition of CCgR may be based on interphase fluorescent in situ hybridization of blood cells, provided that it is performed with BCR-ABL1 extrasignal, dual color, dual fusion, or in situ hybridization probes and that at least 200 nuclei are scored. In many studies, PCgR and CCgR are counted together and reported as MCgR.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Molecular responses are, in general, reported on the evaluation of blood, not marrow samples. For a standardized assessment of the MolR, the conversion of each laboratory data to the international scale is recommended, to correct for the variability of the assays in different laboratories. To allow for intralaboratory variations, a fluctuation of less than one log requires confirmation.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27:6041. Copyright &copy; 2009 American Society of Clinical Oncology. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3981=[""].join("\n");
var outline_f3_56_3981=null;
var title_f3_56_3982="Contents: Obstetrics procedures";
var content_f3_56_3982=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?6/40/6798\">",
"       Obstetrics, Gynecology and Women's Health",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Obstetrics procedures",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Obstetrics procedures",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/8/5252\">",
"           Amnioinfusion: Indications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/12/43203\">",
"           Amnioinfusion: Technique",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/21/14682\">",
"           Cesarean delivery: Technique",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/43/21176\">",
"           Delivery of the fetus in breech presentation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/11/16570\">",
"           Diagnostic amniocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/44/37574\">",
"           Neuraxial analgesia and anesthesia for labor and delivery: Options",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/59/38839\">",
"           Evaluation of stillbirth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/31/11768\">",
"           Fetal blood sampling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40840\">",
"           Gross examination of the placenta",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41752\">",
"           Intrapartum management and outcome of shoulder dystocia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13210\">",
"           Intrauterine fetal transfusion of red blood cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/43/29367\">",
"           Peripartum hysterectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/47/34553\">",
"           Prenatal assessment of gestational age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/25\">",
"           Prenatal sonographic assessment of fetal weight",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/57/42903\">",
"           Procedure for vacuum assisted operative vaginal delivery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/31/40439\">",
"           Pudendal and paracervical block",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/22/3433\">",
"           Repair of episiotomy and perineal lacerations associated with childbirth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/57/15256\">",
"           Techniques for neonatal circumcision",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/0/41993\">",
"           Techniques for ripening the unfavorable cervix prior to induction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11928\">",
"           The fetal biophysical profile",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36824\">",
"           Ultrasound examination in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/55/35702\">",
"           Umbilical cord blood acid-base analysis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-857BE52914-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_56_3982=[""].join("\n");
var outline_f3_56_3982=null;
var title_f3_56_3983="Aphthous lesions Crohns Endosc";
var content_f3_56_3983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aphthous lesions in Crohn's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 230px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Colonoscopy demonstrates small discreet aphthous lesions (superficial ulcerations) that are characteristic of early lesions in Crohn's disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_56_3983=[""].join("\n");
var outline_f3_56_3983=null;
         